Shop for Us

Every 2 minutes someone is diagnosed with lung cancer. Help us change that statistic.

Bookmark and Share
Lung Cancer in the News: 2011 PDF Print E-mail

January | February | March | April | May | June | July
| August | September | October | November | December


Week Ending December 18, 2011

AHS to speed treatment for lung cancer patients
$15.4-million program will attempt to boost lagging survival rate in the province

“Alberta Health Services has set a goal of having most lung cancer patients wait no longer than two months for treatment after being referred for specialized care by a family physician.”

Weakening Cancer Cells for Radiation Therapy
“Cancer has become a normal occurrence in the world nowadays. And as unfortunate as it is, cancer can occur in different parts of the body. However, one in four cancers being diagnosed around the world involves the lung, and is still one the contributors when it comes to the most common cancer-related cause of death among Americans.”

Lung Cancer Alliance Heralds Additional $10.2 Million to Fund Federal Lung Cancer Research
“Today, Lung Cancer Alliance (LCA) announced that its efforts to secure continued increases in federal research funding for lung cancer achieved another victory as an additional $10.2 million was included in the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) which was part of the FY2012 budget compromise worked out late last night by the House and Senate.”

Caregivers get someone to take care of them
New website helps people who care for lung cancer patients

“Friends and relatives caring for lung cancer patients have a new resource to turn to after the recent launch of a 24-hour online service for caregivers by LUNGevity Foundation, the country's largest lung cancer organization.”

New Jersey Senators Sign On in Support of the Lung Cancer Mortality Reduction Act
“Today, Lung Cancer Alliance (LCA) praised Senator Frank R. Lautenberg (D-NJ), Senator Robert Menendez (D-NJ) and Representatives Donald M. Payne (D-NJ) and Steve R. Rothman (D-NJ) for their support for the first comprehensive lung cancer legislation now pending action in the Senate and the House of Representatives.”

Cerulean garners $15M for PhII lung cancer study
“Cambridge, MA-based Cerulean Pharma has banked a $15 million D round from a long lineup of venture backers avid to finance the biotech's Phase II study of its lead drug for non-small cell lung cancer. CVF, an affiliate of Henry Crown and Company, jumped in along with Polaris Venture Partners, Venrock, Lilly Ventures, Lux Capital, and Bessemer Venture Partners.”

AACR & IASLC to Host Molecular Origins of Lung Cancer Conference
“The second AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine will bring together scientists to share the latest findings in the diagnosis, treatment and prevention of the nation’s leading cause of cancer and cancer mortality.”

Study Looks at CT Scans, Cancer Risk
Animal Model Suggests Increased Risk for People with Cancer Susceptibility Genes

“From the doctor’s office to the airport, Americans have more opportunity for radiation exposure than ever before.”

UK lung cancer care improving each year, audit shows
“58.4% of patients with lung cancer in England and Wales and 63.9% in Scotland received an anti-cancer treatment in 2010, compared to 54% and 64.1% respectively in 2008, say new government figures.”

Week Ending December 11, 2011

Targeted drugs, lung screening top cancer advances in 2011
“Leading the list are approvals for a bevy of new, targeted drugs for tough-to-treat malignancies, plus promising results suggesting CT chest scans may be an early-detection screen for lung cancer.”

NCCN Recommends Lung Cancer Screening for People at High Risk
“The National Comprehensive Cancer Network (NCCN)—a not-for-profit alliance of 21 cancer centers—has released guidelines for lung cancer screening. The guidelines recommend screening with helical low-dose computed tomography (LDCT) for selected patients at high risk of the disease.”

Lung cancer patients twice as likely to get treatment if they see a nurse
UK – “Lung cancer patients who see a specialist nurse are twice as likely as other patients with the disease to receive any form of treatment, according to latest data.”

Lung Cancer and the Black Community
“Health statistics tell an ugly story about Black America. African Americans are more likely to die of heart disease, stroke, and HIV/AIDS than any other population group. So too with cancer.”

St. Francis Hospital ushers lung cancer detection technology EAST HARTFORD, CT (WFSB) – “A new technology at Saint Francis Medical Center, called the Electromagnetic Navigation Broncoscopy, acts as a GPS for the lungs, able to identify and biopsy lesions.”

A Look at Smoking Among Hispanic Americans
“Smoking causes more preventable deaths (from lung cancer, heart and lung disease, other cancers, and chronic illness) than any other single behavioral factor––an estimated 443,000 deaths each year in the United States. The most recent data estimates that about 8,400 Hispanic-Americans were expected to be diagnosed with lung cancer in 2009, with the vast majority of these cases caused by smoking.”

Patient Advocate Foundation Announces $9.3 Million Donation to their Co-Pay Relief (CPR) Program
“Additional Funding to CPR Program Will Serve Nonsquamous Non-Small Cell Lung Cancer (NSCLC), Breast Cancer, Colon Cancer, Rheumatoid Arthritis, Hepatitis C Patients in Need of Financial Assistance.”

Atlantic Medical Imaging Introduces Powerful New Weapon in Battle Against Lung Cancer
New Jersey– “Atlantic Medical Imaging (AMI) is now offering low dose CT lung screenings, a breakthrough new tool in the fight against lung cancer. Today, 85% of patients diagnosed with lung cancer in the United States will die from it within five years. With over 160,000 deaths per year, lung cancer has become the number one cancer killer in America, claiming more lives than breast, colon, and prostate cancer combined.”

Is This Drug About To Cure Cancer?
“Peregrine Pharmaceuticals has traditionally been an unknown biopharma player, until now, that is. Peregrine may have uncovered a compound that has extremely high efficacy for lung cancer tumors. If this news ends up being statistically significant, Peregrine could be sitting on a blockbuster drug.”

Week Ending December 4, 2011

More Support For Lung Cancer Legislation as Lung Cancer Awareness Month Draws to a Close
“Today, as Lung Cancer Awareness Month comes to a close, Lung Cancer Alliance (LCA) announced more additions to the growing national network of support for federal action. Backing continues to cover a broad spectrum of interests, ranging from congressional support on Capitol Hill to national and international medical and research organizations, to veterans and labor groups, and to public health advocates.”

New research into lung cancer shows some surprising facts
“In the past, whenever someone was diagnosed with lung cancer, the first question people asked was whether that person smoked. In the recent past, there have been quite a bit different cases, which show that non-smokers are as much at risk of contracting this disease as are smokers. This latest discovery points toward the need for research into the area of lung cancer, and to find out what actually causes this disease.”

Kentucky voices: Federal funds for cancer research are crucial
“As federal lawmakers determine priorities, it is essential to preserve funding for cancer and biomedical research”

Lung Cancer Alliance Thanks Wellpoint, Inc. For Offering Coverage For CT Screening For Lung Cancer
“First and Largest Commercial Membership Payer to Announce Life-Saving Coverage for Those at Risk”

Boehringer will help develop Aveo’s lung cancer candidate
Boehringer Ingelheim has agreed to help oncology specialist firm Aveo develop its lung cancer treatment ficlatuzumab.

“The agreement is for Boehringer to undertake the large-scale process development and clinical manufacturing of ficlatuzumab, Aveo’s novel anti-HGF antibody that is currently in Phase II clinical development for non-small cell lung cancer.”

Roche receives CE mark for it’s cobas EGFR Mutation Test for NSCLC treatment
“Roche, one of the world’s largest biotech companies, reported that the cobas EGFR Mutation Test is now CE marked for commercial availability in Europe and other countries that recognize CE mark.”

Software May Improve Chest X-Ray Detection of Lung Cancer, Shows Early Promise for Pneumonia
OnGuard(TM) Identified Previously Missed and Hard-to-Find Lung Growths

“Sophisticated yet simple-to-use software enhancements to standard chest X-rays may significantly improve early detection of hard-to-find lung cancers and pneumonia, when there are more treatment options, according to three studies being presented at the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Nov. 27 through Dec. 2 in Chicago.”

GSK and ABT expand personalized medicine pact for new cancer diagnostic
“A GlaxoSmithKline cancer drug program will be developed with a new companion diagnostic from Abbott as GSK moves to broaden its reach in personalized medicine.”


Week Ending November 27, 2011

Lung Cancer Caregivers Find Support Online
“Imagine being told out of nowhere that someone you love has lung cancer and their chances of survival look grim. Now, imagine that your loved one doesn’t smoke and is otherwise healthy. . . It happens more than you think.

Lung-cancer screening can save patients' lives
“Lung cancer kills more men and women than any other cancer, and it has been on the rise the last few decades. The number of women lung cancer patients has increased rapidly. The No. 1 cause of lung cancer is smoking; however, people who have never smoked also get lung cancer.”

Study reveals strongest link yet between organ transplants, cancer
New research arms doctors with more information that could lead to reduced risk

“The most comprehensive study ever on the link between organ donations and cancer is arming physicians with new data that could help make the procedures safer.”

Of War and Life: Veteran fought silent battle with cancer, but left a lasting impression
Thirty minutes and he was gone. A million thoughts crossed my mind.

“All Al Henley needed was a good friend who could keep up with his keen sense of humor and laugh with him as each story and joke he told reached its climax. For more than a year, he was battling lung cancer, but it was hard to tell. Other than slight physical changes, there were few signs.”

Four things you didn’t know about smoking and lung cancer
Not all lung cancer is caused by smoking

“For years, anti-smoking campaigns have touted the message – “Smoking causes lung cancer.” Today, you’d be hard-pressed to find any American unaware of the link between the two. However, during Lung Cancer Awareness Month, it’s important to highlight lesser-known facts about lung cancer and smoking.”

Lung Cancer Leading Cause of Death in Beijing
“Lung cancer has become the number one killer in Beijing according to Chinese official sources. The rate of lung cancer diagnosis has gone up nearly 60 percent in the last 10 years.”

Canadians urged to test homes for Radon
“November is Lung Cancer Awareness Month and Health Canada wants to put radon gas on everyone’s radar as the second leading cause of lung cancer behind smoking, because some level of radon can be found in most homes.”

Pfizer effort urges lung cancer patients to get gene tests
“Pfizer Oncology has recruited Desperate Housewives and West Wing star Kathryn Joosten to feature in a national education campaign titled Lung Cancer Profiles, which aims to reduce stigma and plug molecular testing of the disease.”

Week Ending November 20, 2011

Surveys Reveal Wide Gaps in Knowledge of Genetic Mutation Testing Exist Between Oncologists, Nurses and Cancer Patients
“Despite guidelines calling for genetic mutation testing in certain patients with lung cancer, three new surveys fielded by Harris Interactive reveal a disconnect in the understanding of and communication about genetic mutation testing among healthcare professionals and cancer patients.”

Cerulean Pharma enrolling for Phase 2 lung cancer trial
“Cerulean Pharma is moving on to a Phase 2 clinical trial of its new lung cancer drug, CRLX101, boosted by early clinical results suggesting that the treatment is well-tolerated and possibly stops the disease from advancing.”

Merrimack initiates Phase 2 trial of MM-121 with erlotinib
“Merrimack Pharmaceuticals has dosed first patient in a Phase 2 clinical trial of MM-121, in combination with erlotinib (Tarceva) for the treatment of metastatic non-small cell lung cancer (NSCLC).”

Soy Eaters May Have Lower Rates of Lung Cancer
“People who eat a lot of unfermented soy products like tofu may have a smaller chance of getting lung cancer, a fresh look at past research suggests.”

My Turn: After a lung cancer diagnosis, a learning curve
“An angel's push is what Marjorie calls it. It happened on a weekday afternoon in June 2010. I phoned home and found my wife's voice uncharacteristically distraught. The trembling in her breath was unnerving.”

November is National Lung Cancer Awareness Month
“Married for 52 years, Norman and Vivian Hurling are nearly inseparable. They do everything together, from going to the salon, grocery shopping and babysitting their great-grandchildren. Not even lung cancer stood a chance at separating this couple.”

Biothera Phase II Lung Cancer Trial Fully Enrolled
“Biothera's Phase II non-small cell lung cancer (NSCLC) clinical trial evaluating Imprime PGG(R) administered in combination with cetuximab (Erbitux(R)), carboplatin and paclitaxel has met its goal of 90 patients and is fully enrolled, the company announced today.”

American Lung Association Offers Support to Lung Cancer Patients
“This November—National Lung Cancer Awareness Month—the American Lung Association aims to increase public awareness of this deadly disease and encourage action to help prevent and treat it. Lung cancer is the single leading cancer killer of both men and women in the United States. While a major health burden, however, lung cancer remains largely overlooked.”

Week Ending November 13, 2011

Combo ‘epigenetic’ therapy may restore anti-cancer gene activity
“A new type of therapy aimed at reversing the gene silencing that promotes cancer-cell growth has shown promising results in a small clinical trial conducted by researchers at the Johns Hopkins Kimmel Cancer Center. Forty-five late-stage lung cancer patients who received a two-drug combination designed to restore anti-cancer gene activity survived about two months longer than the expected four months, and two patients showed complete or near-complete responses despite having progressive disease after multiple standard therapie.”

Inoperable Lung Cancer Patients Worried About Family's Fears
“I've been touched when I hear lung cancer survivors say that their biggest concern is their family's feelings. My gut would say something different. Like -- perhaps -- their treatment and survival would come first?”

Easing the stress for lung cancer patients
“Erika Muto didn't trust doctors. Or nurses. Or hospitals, for that matter. Truth told, she had no use for the medical profession. Never had a good experience with them and wasn't anxious to try again.”

Gilda’s Club South Jersey to Hold Lung Cancer Lecture
“In observance of Lung Cancer Awareness Month, AtlantiCare in partnership with Gilda’s Club South Jersey, will hold a free lung cancer workshop Fri., Nov. 18 from 12 to 1:30 p.m. at AtlantiCare, the Cancer Care Institute, a Fox Chase Cancer Center Partner, AtlantiCare Health Park, 2500 English Creek Avenue, Egg Harbor Township. Lunch and light refreshments will be provided.”

Lung cancer
“For years, anti-smoking campaigns have touted the same message – “Smoking Causes Lung Cancer.” Today, you’d be hard-pressed to find any American unaware of the strong link between the two. However, during Lung Cancer Awareness Month in November, it’s important to highlight some lesser-known facts about lung cancer and smoking that can still have a big impact on your health.”

'Breakthrough' Lung Cancer Therapy Tested in Colorado
AURORA, Colo. – “Two-and-a-half years ago, Joe Trujillo, a non-smoker, was diagnosed with stage-4 lung cancer.”

University of Iowa study tests ketogenic diet for lung and pancreatic cancers
IOWA CITY – “Researchers with UI Health Care have received a two-year, $340,023 grant from the National Cancer Institute to investigate whether a ketogenic diet can increase the effectiveness of radiation and chemotherapy for lung and pancreatic cancer.”

Week Ending November 6, 2011

Millburn student is semi-finalist in Siemens competition
“Millburn High School senior Rachel Okrent is a semifinalist in this year’s Siemens Competition in Math, Science and Technology. She is one of 300 semifinalists in this year’s competition that had an unprecedented 1,541 projects submitted.”

Lung Cancer Awareness Month: Focus on Importance of Screening
“November is Lung Cancer Awareness Month, and as in other observances, now is a good a time as any to focus on sharing information about this disease, and about the important role that early detection plays in its treatment and management.”

Lung cancer impacts 1 in 14 Americans
“November is lung cancer awareness month. It's a disease that impacts one in 14 Americans, and kills more than breast, prostate, colorectal, leukemia, and melanoma cancers combined.”

Cetuximab Extends Lifespan Of Lung Cancer Patients With High EGFR Expression
“A study published Online First in The Lancet Oncology reveals that patients who suffer from the most common form of lung cancer and whose tumors express high levels of epidermal growth factor receptor (EGFR) tend to benefit more from being treated with cetuximab and have a longer life-expectancy compared with those given chemotherapy alone.”

Radiotherapy Centers of Kentuckiana Reminds Local Residents of the Dangers of Smoking
“This year alone, the American Cancer Society estimates approximately 221,130 people in the U.S. will be diagnosed with lung cancer and an estimated 156,940 people will die. In Kentucky each year, approximately 77 percent of people die from the disease, while approximately 63 percent of people die in Indiana. November is Lung Cancer Awareness Month and Radiotherapy Centers of Kentuckiana reminds the community of the dangers of smoking and encourages all local residents to mind their lungs, their health and their loved ones, and quit.”

Could Pollution Increase Lung Cancer Risk?
“Even people who've never touched a cigarette have a higher risk of dying from lung cancer if they live in highly polluted areas, according to a new study.”


Week Ending October 31, 2011

Niagara Falls to Be Lit Up for Lung Cancer
“Lung cancer needs to be noticed. And I can't think of a more roaring way than lighting up Niagara Falls.”

EU nod for Alimta as continuation maintenance therapy for most common form of lung cancer
“The European Commission has granted approval for Eli Lilly and Company’s Alimta (pemetrexed for injection) as a single agent for continuation maintenance therapy in patients with a particular type of lung cancer, called advanced non-squamous non-small cell lung cancer (NSCLC).”

Losing my mom to lung cancer & the mission ahead
“November has been designated National Lung Cancer Awareness Month and Action News is beginning a very special series on this disease which is the second most commonly diagnosed cancer in the country.”

Air pollution tied to lung cancer in non-smokers
(Reuters Health) – “People who have never smoked, but who live in areas with higher air pollution levels, are roughly 20 percent more likely to die from lung cancer than people who live with cleaner air, researchers conclude in a new study.”

The biggest cancer killer of women (and men)
You wouldn’t know it from the Get Pink’d! campaign, but lung cancer kills far more women than breast cancer

“Did you Get Pink’d! on Thursday? Whether you did or not, you probably heard about the event, which encourages people to wear pink in support of a future without breast cancer. Get Pink’d! is also just one of literally thousands of high profile events directed at raising awareness and funds to combat breast cancer.”

Week Ending October 23, 2011

Alcohol Linked to Lung Cancer
“Having a beer belly should be of least concern for alcohol users. According to three recent studies, heavy alcohol consumption is linked to a great risk of developing lung cancer, while specific ethnic groups, including African American men and Asian women, had slightly higher risks for lung cancer.”

Lung cancer vaccine TG4010 shows promising results
“A team of researchers at the Strasbourg University has claimed that an experimental vaccine, called TG4010, has certainly given some promising results in fighting against lung cancer.”

Boston University Receives $13.6 Million to Develop Tools for the Early Detection of Lung Cancer
“The Boston University School of Medicine (BUSM) has received a $13.6 million grant from the U.S. Department of Defense’s Lung Cancer Research Program. The University will be the lead institution in a study aimed at developing technologies for the early detection of lung cancer. The five-year grant will focus on active military personnel and veterans, and BUSM will collaborate with military hospitals and Veteran’s Affairs medical centers nationwide to gain access to a variety of researchers and tools.”

Depression During Lung Cancer Treatment Linked With Lower Survival
“Depression during cancer treatment certainly lowers a person's quality of life. But it appears -- at least when it is present at the time of the first chemotherapy session for people with advanced lung cancer -- to be associated with a lower survival rate as well.”

The Lung Cancer Research Foundation Announces 2011 Grant Recipients and Scientific Merit Award in Recognition of November as Lung Cancer Awareness Month
“Understanding the genomic structure of lung cancer cells and the mechanisms that trigger their growth is the basis of research underway by Adam Bass, MD, winner of the 2011 Scientific Merit Award who will be celebrated at The Lung Cancer Research Foundation's third annual Lung Cancer Symposium, on November 1st in New York.”

Jordan Hospital offers free lung cancer screenings - Milton, MA - Wicked Local Milton
PLYMOUTH — “Jordan Hospital will offer free lung cancer screenings Nov. 7-18. The screenings will consist of one low-dose, non-contrast chest CT scan. The program is for asymptomatic men and women 55 to 74 years old with a history of smoking and for former smokers who quit less than 15 years ago and have no history of cancer except non-melanoma skin cancer.”

LUNGevity Foundation Receives Lung Cancer Advocacy Award
“LUNGevity Foundation is the recipient of the University of Pennsylvania's Abramson Cancer Center Lung Cancer Advocacy Award in recognition of their Outstanding Research and Patient Education.”

Week Ending October 16, 2011

Radon Action Week set for Oct. 17 to 24
“Oct. 17 to 24 is Federal Radon Action Week according to the surgeon general. Health agencies throughout the United States have joined forces to promote awareness of the leading cause of lung cancer for non-smokers. The American Lung Association, Centers for Disease Control, and National Cancer Institute all agree that radon is a national health problem and encourage radon testing during the October awareness drive.”

Experts Discuss Emerging Treatments and Advanced Approaches to Radiotherapy Treatments for Lung, Liver, and Breast Cancer
Several presenters report promising results with radiosurgery, a non-invasive alternative to surgical intervention

“Positioning breast cancer patients on their stomachs rather than their backs for radiotherapy could lead to better outcomes, according to a radiation oncologist who was among several clinical experts speaking in front of more than 500 oncology professionals about advances in cancer care at a symposium in Miami Beach, Florida, last week.”

Lessening the Mortality of Advanced Lung Cancer
“University of Colorado Cancer Center’s researchers have devised a tool that will help identify key biomarkers in advanced lung cancer. In a clinical trial, the said tool was said to have decreased the risk of death by 36% for the past thirty month period.”

Local hospitals screen smokers for cancer Local hospitals are offering low-dose CT scans to smokers to screen for lung cancer.
“Heavy smokers who are worried about lung cancer can now be screened for the disease with low-dose CT scans.”

Lung cancer patients with diabetes show prolonged survival
“Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer.”

Fireys want cancer-link law
Australia – “Nathan Ractliffe's father died of lung cancer when he was 62. A non-smoker, he had served as a volunteer firefighter at Bacchus Marsh CFA for more than 35 years.”

UCSF Radiology Encourages Low- dose CT with Lung Cancer Screening Program
“At UCSF, radiologists understand the importance of minimizing patient exposure to radiation, while obtaining the highest quality of results from CT scans. For this reason, UCSF places an emphasis on performing low- dose CT scans whenever possible. UCSF radiologists are combining new scanning protocols and imaging software to ensure maximum information with minimum radiation dosage for each scan.”

Week Ending October 9, 2011

Small cell lung cancer secret solved by Australian scientists
“Australian scientists have helped unlock the secret of how a deadly lung cancer manages to regenerate despite being blasted with chemotherapy. Researchers from Monash University in Melbourne teamed up with colleagues in the United States to make the discovery, which they believe could have major implications for the future treatment of millions of cancer patients.”

New Treatment Shows Promise in Lung Cancer Treatment
“F-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) scans benefit patients with stage II and III inoperable non-small cell lung cancer (NSCLC), reveals study.”

New treatment gives hope to lung cancer patients
FAIRFIELD, Maine – “Patients diagnosed with early stage lung cancer are often treated by surgically removing part or all of the affected lung. But a cutting edge and less invasive treatment available in Maine, is giving patients a much better chance at survival.”

Compassion Leaves Lasting Impression on Lung Cancer Patient
“As a nurse of 40 years, Nancy Beck knows what it means to put others first. But, that mentality would have to change after going in for a normal screening mammography and coming out worried about a suspicious area, which proved to be positive for breast cancer.

A few weeks later, Beck returned to have her surgery. She had a full pre-operative exam, and everything looked good, except for her chest x-ray. Beck was about to face the stress of having a double diagnosis of early stage breast and lung cancer.”

How Green Tea May Thwart Lung Cancer
“A new study shows for the first time how a compound in green tea might work to suppress lung cancer. A compound found in green tea, called EGCG, was already known to have anti-cancer properties. But researchers are still trying to figure out all the ways EGCG acts to suppress tumor growth.”

LabCorp To Offer A New Companion Diagnostic For Non-Small Cell Lung Cancer
“Laboratory Corporation of America Holdings (LabCorp) announced recently the nationwide availability of a new FDA-approved companion diagnostic for lung cancer patients.”

More options allowing patients to live longer
HOT SPRINGS, Ark. (KTHV)—“Not only are doctors using different therapies to treat lung cancer patients; they're better defining the different types of lung cancer. For patients, it means higher survival rates and more options.”

Everyday Cancer Risk No. 4
“Most of our homes have radon detectors. It's sort of a chic domestic thing these days, and they give us a sense of security. But what do you do it the detector goes off? And what is radon, anyway?”

Week Ending October 2, 2011

'Always hope,' cancer survivor says: Faye Hurbis, now free of breast and lung cancer, volunteers to help other patients
“Baking muffins, reading stacks of books and volunteering at the hospital helped Faye Hurbis get through her diagnosis and treatment of breast cancer. She was determined not to let the disease keep her down.”

Array says drug misses statistical significance
“Array BioPharma Inc. said Friday the potential lung cancer treatment selumetinib produced a greater increase in survival compared to patients taking another course of treatment in a mid-stage trial, but the difference was not statistically significant.”

Calypso granted IDE approval for pivotal lung cancer study
“Calypso Medical Technologies, Inc., developer of real-time localization technology used for precise tumor tracking, announced that the U.S. Food and Drug Administration (FDA) granted Investigational Device Exemption (IDE) approval for its clinical study evaluating real-time tracking of lung cancer tumors during radiation delivery. Patient enrollment is planned at Washington University in St. Louis, and the Cancer Treatment Centers of America in Tulsa, Oklahoma. Investigators in the United States will implant three anchored Beacon® transponders in patients’ lungs and use the Calypso® System to precisely track tumor location and movement during lung cancer radiation therapy.”

St. Jude Children's Research Hospital work is basis for new anti-cancer drug
“Drug giant Pfizer has launched a new adult cancer drug born from research started at St. Jude Children's Research Hospital more than 20 years ago.”

Tobacco firms kept radioactive link secret
“Tobacco companies knew for decades that cigarette smoke was radioactive and potentially carcinogenic but kept the information from the public, a new study says.”

Eli Lilly's Alimta For Lung Cancer Gets Positive Opinion From CHMP
“Eli Lilly and Co. said its Alimta or pemetrexed for injection received a positive opinion from European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP as continuation maintenance therapy in patients with advanced non-squamous non-small cell lung cancer. Based on the recommendation, European Commission would approve the indication in Europe.”

Pemetrexed/Bevacizumab Maintenance Combo Stalls Lung Cancer
“Adding pemetrexed to bevacizumab maintenance therapy cut the relative risk of disease progression for patients with advanced nonsquamous non–small cell lung cancer in a phase III clinical trial.”

More people surviving lung cancer in Northern Ireland
“More people in Northern Ireland are surviving lung cancer thanks to the speed of diagnosis and treatment.”


Week Ending September 18, 2011

Clinical trials may offer answers
Cancer survivor describes benefits

“Debbie Violette decided traditional treatment had very little chance of treating her lung cancer.”

Researchers unveil new method for detecting lung cancer
“Michael Wang, M.D., Ph.D., right, assistant professor of pathology and anatomical sciences, and Li-Qun Gu, Ph.D., associate professor of biological engineering, have developed a new technology for the early detection of lung cancer. Worldwide and in the United States, lung cancer is the most common cause of cancer-related death.”

U.S. lung cancer rates decline: CDC
“The rates of new lung cancer cases in the United States dropped among men in 35 states and among women in six states between 1999 and 2008, according to a report released Thursday by the Centres for Disease Control and Prevention (CDC).”

Support for Congressional Action on Lung Cancer Continues to Grow; Covers Broad Spectrum
“Today, Lung Cancer Alliance (LCA) announced recent additions to the growing network of support for federal action on lung cancer that covers a broad spectrum of interests, ranging from national medical and international research organizations, to veterans and labor groups, to public health advocates, and to congressional support on Capitol Hill.”

Spotlight on Cancer Diagnostic Tech: What is GE Clarient’s Multiplexing?
“One of the key breakthroughs in molecular pathology, an important part of cancer diagnosis, is a technique called “multiplex immunohistochemistry.” This multiplexing is being developed at GE Global Research in Niskayuna, New York and will be used by GE company Clarient for product development. Multiplexing is just one of several new technologies in the works to help drive innovation in GE’s campaign against cancer. GE Reports talked to John Burczak, Ph.D., Chief Scientist for molecular imaging projects at GE Global Research, about how multiplexing works and how GE’s approach could help provide a more comprehensive view of the disease for doctors.”

Roche Presents Data On New Breast, Lung, Skin Cancer Approaches
“Roche Holding AG Monday announced that encouraging data on its investigational and approved medicines will be presented at the 2011 European Multidisciplinary Cancer Congress in Stockholm being held 23-27 September 2011.”

Lung Cancer Symptoms in Non-Smokers May Be Different
“There have been many changes in medicine since I was in medical school, but one thing remains constant. The importance of knowing the symptoms of a disease has little to do with how much voice it gets.”

Lung cancer patients deserve greater support, whether they smoke or not
“Each year 40,000 Australians die from cancer-related illness – the number one cause being lung cancer.”

LUNGevity Pushes For Early Detection For Lung Cancer
“Lung Cancer is the country's top cancer killer and it claims the lives of twice as many women as breast cancer. Creating a world where no one dies of this disease is the mission of the LUNGevity Foundation.”

Allsup Explains Social Security Disability Considerations for Lung Cancer
“The most common cause of cancer death is lung cancer, according to the American Lung Association (ALA). Because many who suffer with lung cancer face serious physical and emotional challenges that keep them from working, it’s important to consider applying for Social Security Disability Insurance (SSDI) benefits as soon as possible, according to Allsup, which represents tens of thousands people nationwide in the SSDI application process each year. Those who suffer with the debilitating condition also should make certain they understand the Social Security Administration’s (SSA) disability insurance evaluation process and requirements as it relates to this devastating disease.”

A ray of hope for some lung cancer patients
“A new treatment standard may be in the making for some patients with lung cancer, a study headed by Winship Cancer Institute's executive director suggests.”

Week Ending September 11, 2011

Lung cancer high in both women and men
“Cases of lung cancer are on the increase in both women and men in old age, this is according to Kampala cancer registrar Henry Wabinga. He said that the incidence of cancer of lungs since 1954 is now four –folds in increase and this is both in women and men.”

Symptoms of Lung Cancer in Non-Smokers
Why Do They Differ From Those in Smokers?

“Symptoms of lung cancer in non-smokers may be different from lung cancer in people who smoke. Sometimes the symptoms may be more subtle, such as shortness of breath with activity, or hard to define, such as fatigue. What are some common symptoms of lung cancer in non-smokers and why might they be different from those in smokers?”

JNCI: Concurrent chemo, radiotherapy for lung cancer boosts survival
“Treating some lung cancer patients with concurrent chemotherapy and radiation therapy significantly increased five-year survival rates vs. waiting to treat patients with radiation therapy after completing chemotherapy, according to a study published Sept. 8 in the Journal of the National Cancer Institute.”

Study finds hospitals of last resort deliver lower quality of lung cancer care
“A new study finds that lung cancer patients treated in hospitals that care for a high percentage of uninsured and Medicaid-insured patients, so-called "high safety-net burden facilities," were significantly less likely to undergo surgery that was intended to cure the cancer compared to patients treated at low safety-net burden facilities. This difference persisted even after controlling for other factors that significantly decreased the likelihood of curative-intent surgery, such as race, insurance status, stage, and female gender as well as other hospital characteristics.”

Amarilloan outlives doctor's expectations
“What began as a bump on Don Turner’s chest soon was found to be evidence of rampant cancer that threatened to leave the Amarillo man with little hope.”

Alchemia to start lung cancer drug trial
“Biotechnology firm Alchemia has started to recruit patients for a phase II trial of its drug to treat small cell lung cancer.”

Peregrine Completes Patient Enrollment in Randomized Phase II Trial for Bavituximab in Front-Line Non-Small Cell Lung Cancer
Interim Data Expected by Year End Peer-Reviewed Publication of Bavituximab Clinical and Preclinical Data in Immunotherapy

“Peregrine Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced the completion of enrollment and randomization of 86 patients with previously untreated non-small cell lung cancer (NSCLC) in a Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel.”

More Than Half of Americans Are Unaware Lung Cancer is the Leading Cause of Cancer Deaths (i)
“Each year, lung cancer claims more than 160,000 lives (ii) in the United States. This is greater mortality than all breast, colon and prostate deaths combined (iii). Yet, lung cancer receives nine-times less funding than breast cancer. For every $9 spent on breast cancer research, only $1 is spent on research for lung cancer in the U.S. (iv) Despite the fact that lung cancer is the leading cause of cancer deaths, survey results announced today by the Lung Cancer Research Foundation (LCRF) reveal that 60% of the American population are unaware that lung cancer is the deadliest form of cancer.”

AIM: Dueling editorials debate pros, cons of CT lung cancer screening
“To screen for lung cancer, or not to screen? That is the question that referring clinicians across the country face in the wake of the National Lung Screening Trial (NLST). While radiologists may be ideally situated to help physicians wade through the nuances of the question, a group of clinicians debated the question in two articles published online Sept. 5 in Annals of Internal Medicine.”

Week Ending September 4, 2011

Navigating cancer: Nurses lead patients through difficult process
“Betty Price doesn't remember much about that April morning at Baptist Memorial Hospital-Golden Triangle. She remembers the pain and the way she couldn't stop crying. She remembers sitting next to her husband, Otis Price, and learning that her persistent cough was not pneumonia -- it was lung cancer.”

Pemetrexed Efficacy Prediction With Lung Cancer ALK Rearrangement: Study
“Patients with ALK-rearranged non-small cell lung cancer (NSCLC) responded significantly better to pemetrexed (brand name: Alimta) than patients whose cancer did not show ALK translocation, according to research published in the September issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC).”

Homes to be tested for Radon Gas
“Homes in the Channel Islands are to be tested for Radon gas. This follows calls from a Jerseyman who fears his father's death was caused by a build-up of radon in his house.”

Study Says Fibrous Stroma Associated With Poor Prognosis in Lung Cancer
“The nature of connective tissue that surrounds lung cancer can help predict the aggressiveness of squamous cell carcinoma, shows study published in Journal of Thoracic Oncology.”

Team makes lung cancer breakthrough
“A medical research team funded by the National Science Council (NSC) said it has discovered how to predict the effectiveness of targeted lung cancer therapies. The discovery would help doctors decide if they should to switch to alternative treatment methods for the 20 to 30 percent of patients for whom targeted therapy is currently ineffective, the team said.”

Lung Cancer: The Inflammation Connection
“Catching pneumonia is a surprising way to prevent lung cancer, according to a study from the National Cancer Institute. Respiratory tract infections are generally thought to promote lung cancer through changes to the airway. Jill Koshiol and colleagues performed a study to see how pneumonia affects lung cancer risk. In contrast to chronic inflammatory respiratory conditions, pneumonia was associated with reduced cancer risk.”

New high tech CT scan may help in lung cancer fight
TAMPA, Fla. – “Every year, lung cancer kills more Americans than colon, breast and prostate cancers combined.”

The silent disease that's ending women's lives
“THE most shocking thing about the news that lung cancer kills more women than breast cancer does is that the former is almost entirely preventable. Unlike breast cancer, about which we hear an awful lot more and which can strike the most clean living young woman, lung cancer in the vast majority of cases is associated with smoking.”


Week Ending August 29, 2011

Martin-O’Neil Cancer Center Offers Cancer Patients Fewer Treatments By Using New Technology That Precisely Delivers Radiation to Tumors
“St. Helena Hospital’s Martin-O’Neil Cancer Center is adding another leading-edge radiation therapy to its treatment regimens. Stereotactic Body Radiation Therapy (SBRT) also known as Sterotactic Ablative Body Radiotherapy (SABR) is a pinpoint-accurate radiation delivery system designed to precisely target cancer tissue while sparing healthy surrounding tissue.”

Doctors Report Improving Prediction of Cancer Survival Rates
“Sniffer dogs detecting lung cancer and modified "ecstasy," seen as a potential treatment for myeloma, lymphoma and leukaemia, might be ground-breaking discoveries, but the disease remains a physical, mental and financial challenge for patients.”

FDA approves gene-targeting lung cancer drug
“The twice-a-day pill, called Xalkori, is part of a new wave of personalized medications that fight disease by targeting specific genes found in certain patients. Last week, the FDA approved another drug that uses similar gene targeting technology to treat two rare forms of lymph node cancer.”

Chemo drug shortage may start impacting patients
“New Brunswick physicians may come under increased pressure on how they treat patients if a drug shortage continues much longer, according to a cancer specialist.”

Early morning smoking increase risk of disease
“Researchers from Columbia University’s Mailman School of Public Health and Penn State College of Medicine analyzed 4,775 lung cancer patients and 2,835 control subjects to establish the link; all of whom were smokers. They found during their respective studies that individuals who smoke 31 to 60 minutes after waking were nearly 1 and half times more likely to develop cancer.”

CT, PET-CT, MRT and transthoracic ultrasound in lung cancer staging
“Dr Helmut Prosch, at the University Clinic for Radio-Diagnostics, Vienna, Austria, is examining the role of imaging in lung cancer diagnosis and staging. The key message of his presentation in the session EUS and EBUS vs. CT, MR and PET-CT in the staging of lung cancer is that the modalities do not compete with one another – as the title suggests – but are perfectly complimentary in the diagnostic flow.”

Activation of Cellular Pathway by Nickel Nanoparticles May Trigger Lung Cancer
Brown “University researchers have discovered that nickel nanoparticles trigger a cellular pathway called HIF-1 alpha that leads to cancer in human lung cells.”

Even in advanced lung cancer, exercise offers benefits
“Doctors should feel comfortable prescribing exercise for these patients, said Dr. Morten Quist, who led the study. "It's just very important to tell them that it looks like you can get more energy, you can do more things in daily life if you actually are active," he told Reuters Health. "That's a big beneficial improvement both mentally and physically."

Premiere Oncology Announces Initiation of Clinical Trial of Novel Non-small Cell Lung Cancer Drug
“Premiere Oncology today announced that it is participating in a Phase 2b/3 clinical trial of ganetespib, a novel, potent anti-cancer drug in combination with docetaxel, an approved chemotherapy drug, for the treatment of non-small cell lung cancer patients.”

Week Ending August 14, 2011

End-of-life discussions provide peace, closure (with videos)
“As a nurse for almost two decades, Debbie Elko of Claridon Township witnessed firsthand the turmoil families must deal with when a terminally ill loved one is unable to provide directives for their end-of-life wishes.”

Early Morning Smokers May Have Higher Cancer Risk
“Science has shown that smoking or even being exposed to second-hand smoke increases the risk of developing lung cancer. A U.S. Surgeon General’s Report released in December 2010 stated that “smoking causes more than 85 percent of all lung cancers and can cause cancer almost anywhere in the body.””

Science, Government and Industry Converge in National Call to Action on Lung Cancer
“The New England Journal of Medicine's recent publication of the landmark National Lung Screening Trial (NLST), along with two congressional initiatives and an industry report, beacon a much brighter future for Lung Cancer patients.”

Flaxseed Might Protect Against Death from Radiation
“Flaxseed may protect against the damaging effects of radiation, whether from a terrorist's dirty bomb or a routine cancer treatment, a new study in mice suggests.”

Elderly Lung Cancer Patients Can Gain From Two-Drug Chemo: Study
Finding runs counter to expert recommendations against use of the therapy by those over 70

(HealthDay News) – “Countering conventional wisdom, researchers in France say that elderly lung cancer patients can gain significant benefit from an aggressive, double-barreled chemotherapy that's often used in younger patients.”

Jury orders Philip Morris USA Inc. to pay $12.8 million to son for father’s lung cancer death
“A jury Tuesday ordered Philip Morris USA Inc. to pay $12.8 million to the 19-year-old son of a man who died of lung cancer from smoking Marlboro cigarettes.”

Scientific Presentations at 2011 AAPM/COMP Meeting Highlight TrueBeam® and RapidArc® Radiotherapy Systems From Varian Medical Systems
“Medical physicists researching RapidArc® radiotherapy technology from Varian Medical Systems have reported that, compared with conventional approaches to radiotherapy, RapidArc treatment plans for lung, abdominal and spinal tumors do a better job of sparing healthy tissues and organs.”

Week Ending August 7, 2011

Study: Inexpensive method detects ALK rearrangement in lung cancer patients
“A relatively simple and inexpensive method may be used to determine whether a lung cancer patient is a candidate for crizotinib therapy, according to research published in the August issue of the Journal of Thoracic Oncology, the official monthly journal of the International Association for the Study of Lung Cancer (IASLC).”

CT Lung Cancer Screenings Being Offered at Moffitt
“The Moffitt Cancer Center in Tampa, among others, has begun a CT lung cancer screening program, based upon a recent groundbreaking study that has shown it to be effective in early detection of the disease.”

For your lungs’ sake St. Joe’s is the go-to centre
“St. Joseph’s Hospital is now the regional thoracic centre for the area’s Local Health Integration Network.”

Lung Cancer Survivor Coauthors Roadmap for 'Fighting Back' in Face of Staggering Odds
“The fantastic news of Rosann Plautz's survival is by no means the end of her fight, but it's a long way from when her doctors told her she was going to die: "There are no alternatives; you are going to die." Her first medical oncologist dismissed the PET scan results that showed the cancer had not spread: "Once it's spread to the brain nothing else matters." Hospice intake nurses estimated Rosann had three months to live.”

US, Japan Join Hands for Developing Lung Cancer Drug
“In a much-warranted step, a prospective drug for tackling lung cancer is being developed by scientists at the Auckland Cancer Society Research Centre and the Maurice Wilkins research centre. After PR509 was discovered, under a deal between Japanese pharmaceutical company Yakult Honsha and American biotechnology company Proacta, drug, called PR610, is being seen as a potential treatment for lung cancer.”

Lung cancer is most common cause of cancer-related death, tied to smoking, genes
“Dr. Charles Powell, chief of the pulmonary, critical care and sleep medicine division at Mount Sinai, specializes in identifying and treating patients with early-stage lung cancer. His division oversees the care of several hundred lung-cancer patients a year.”

Using high technology to fight lung cancer
“Lung cancer remains the most common cause of cancer death for both men and women throughout the world.”

Geisinger’s ProvenCare Lung Cancer Collaborative Highlighted in Journal
DANVILLE, Pa. – “Leaders of Geisinger Health System’s ProvenCare® Lung Cancer program have partnered with health care providers across the country in an effort to replicate the program’s effectiveness with treating lung cancer patients.”


Week Ending July 31, 2011

Cancer patients participating in studies are key to cure
“When Donald Turner was diagnosed with stage IV lung cancer in December 2007, his Texas Oncology physician was honest with him that his prognosis was not good. Even with treatment, it was likely that he would not live longer than two years. Donald had a large tumor on his lung, and the cancer had also spread to his ribcage.”

CU-Boulder student taking steps towards cancer research
“The past six months, University of Colorado student Minh Than, who will be a senior this fall, has been exposed to cancer for the first time in his life.”

Tobacco used in lung cancer research.
Kentucky has known tobacco for more than 200 years -- not just as a cash crop, but a way of life.

“Ray Tucker's tobacco farming ancestors helped make Louisville the biggest tobacco market in the country. He's sixth generation tobacco farmer with their family farm dating back to 1847.”

A Faster, Cheaper Test For Lung Cancer
Noninvasive test earns Avrum Spira Innovator of the Year award

“Technology that makes possible a new, noninvasive method for the early detection of lung cancer has earned Avrum Spira, an associate professor at the School of Medicine, the 2011 Innovator of the Year award, given to a BU faculty member whose research led to the formation of companies that benefit society at large.”

Living in a probabilistic world
Risk is not certainty. There is seldom a ‘one on one’ nexus between any risk factor and a negative health outcome.

“Whenever I give a talk on “Smoking and Cancer”, one question inevitably pops up. “Doctor, my grandfather smoked 40 cigarettes a year for 60 years and he never contracted lung cancer. Can you comment on this, please?””

Roswell: Screening trial offers hope against lung cancer
“Lung cancer is the deadliest of all cancers, claiming more lives each year than breast, colon, kidney, liver and melanoma cancers combined. That’s largely because lung cancer is only rarely detected at the earliest and most treatable stages. Dauntingly, when lung cancer is discovered, symptoms are present and the disease has metastasized beyond the lungs.”

Exercise benefits lung cancer survivors
“Progressive resistance exercise training might be helpful for selected lung cancer survivors, a new study from Canada and Australia suggests.”

Conquer cancer: ‘Early diagnosis saves lives’
“Stark and frightening figures for Peterborough show that the city has little awareness of major symptoms for the three main types of cancer.”

US Report Once Again Identifies Asbestos as a Known Carcinogen that Causes Mesothelioma and Lung Cancer
“Mesothelioma is an aggressive, incurable cancer caused by asbestos exposure that often leaves patients with few treatment options and a prognosis of less than one year after diagnosis. Asbestos was widely used in building materials in homes, schools, factories and other industrial settings for much of the 20th century. Its use was largely restricted in the late 1970s because of its toxicity. The heavy use of asbestos left workers and their families who breathed asbestos dust decades ago vulnerable to contracting the asbestos cancer, which typically takes 30 years or more to present symptoms”.

Drug Triples Lung Cancer Survival
“The cancer drug Tarceva (erlotinib) almost triples the survival time of lung cancer patients with almost no negative effects, says a study published in Lancet Oncology. Patients who received the drug, which is widely available, survived an average of 13.1 months before their cancer recurred compared to only 4.6 months in a group that received chemotherapy.”

Week Ending July 24, 2011

Lung Cancer Rates Increase Among British Women
“A new report by the group Cancer Research UK compares lung cancer rates in the British population from 1975 to 2008. The report showed that the number of women over sixty years of age diagnosed with lung cancer jumped from 5,700 in 1975 to 15,100 in 2008, an increase of nearly 165 percent in just over thirty years.”

Lung Cancer Slowed by First-Line EGFR Inhibition
“Patients with advanced lung cancer had a threefold improvement in progression-free survival with first-line erlotinib (Tarceva) instead of chemotherapy, final results of a randomized trial showed.”

Scientists uncover role gene plays in small cell lung cancer
“US scientists have used cutting-edge gene sequencing technology to identify a gene that might be involved in the progression of small cell lung cancer.”

African Americans and tobacco: It’s time to ‘butt’ out
““Big Tobacco” may be on the ropes again after a recent court ruling requiring that one company, Lorillard, pay out $152 million in a wrongful death suit. A Massachusetts court has ruled in favor of the family of Marie Evans eight years after she died from lung cancer. The case was strengthened by documents used in the trial that showed Lorillard purposely marketed its Newport cigarettes to African Americans such as Evans when they were teenagers.”

Education, tests needed about radon, its risks
“Have you tested your home for radon within the past two years? What was the result?”

Stacking the pack against smoking: ECH study assesses lung-cancer risk
“For 33 years, Jennifer Martin smoked a pack of cigarettes each day and didn’t think twice about lighting up the stick that comes in a pack with nasty pictures and a dire warning to smokers of the havoc tobacco can wreak on human health. Working at El Camino Hospital’s nonsmoking campus in Mountain View didn’t make her think twice, either. Until three years ago.”

SBRT for Medically Inoperable Early Stage Lung Cancer a Key Topic for Elekta Presenters at Lung Cancer Conference
“During the 14th World Conference on Lung Cancer, leading users of Elekta Stereotactic Body Radiation Therapy (SBRT) technology presented their findings on the use of SBRT to treat early stage, non-small cell lung cancer (NSCLC). The most common form of lung cancer, NSCLC arises from a number of causes, including active smoking, passive smoking (secondhand smoke), and exposure to other carcinogens.”

Day at the Races to aid lung cancer research
“Unlike nearly everyone who has suffered from pneumonia, Paula Zinnemann feels “blessed” to have been diagnosed with the lung infection.”

Hospice Enrollment and Lung Cancer Survival
“Simply hearing the word "hospice" conjures about anxious emotions for many people. And it's not just people living with cancer and their loved ones. Physicians are often hesitant to bring up hospice care as well. For both patients and physicians, talking about hospice can be associated with a "feeling of giving up." At least from a physical/survival point of view.”

Synta Announces First Patient Treated in the GALAXY Trial(TM) a Phase 2b/3 Trial for
“Ganetespib in Advanced 2nd-line Non-small Cell Lung Cancer Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in a Phase 2b/3 clinical trial of ganetespib in combination with docetaxel in non-small cell lung cancer (NSCLC).”

Week Ending July 18, 2011

Pharmafocus presents selected highlights from the American Society of Clinical Oncology's annual meeting in Chicago, beginning with non-small cell lung cancer (NSCLC).
“Pfizer’s targeted NSCLC treatment crizotinib was one of the highlights of ASCO last year and now looks set to gain approval in record time, and is likely to hit the market by early 2012.”

Study bolsters evidence that screening reduces lung cancer deaths
“Closer analysis of a trial finds that spiral CT scans pose few serious complications and can cut lung cancer rates among smokers and ex-smokers by 20%.”

Lung cancer scans can be unreliable - study
“CT scans to measure lung tumors can be unreliable, potentially leading patients and doctors to believe cancer is growing when it's not, according to a study.”

Study bolsters evidence that screening reduces lung cancer deaths
“Closer analysis of a trial finds that spiral CT scans pose few serious complications and can cut lung cancer rates among smokers and ex-smokers by 20%.”

R.I. Hospital part of study that finds CT scans could cut lung cancer deaths
“A recent clinical trial has identified, for the first time, a possible way to detect lung cancer in early and more treatable forms. The National Lung Screening Trial found that screening heavy smokers between the ages of 55 and 75 with annual CT scans could reduce lung cancer deaths by 20 percent.”

Few Steps Taken to Address Iowa’s Growing Radon Threat
“The second-leading cause of lung cancer is radon — a colorless, odorless gas that seeps into buildings through cracks in walls and foundations. The gas, produced by decaying uranium deposited in the soil by glacial activity, kills more than 21,000 Americans each year, according to the Environmental Protection Agency. About 400 of those deaths are Iowans.”

New local technology to help detect lung cancer
Results are part of a four-year pilot project

“Local researchers have developed new technology to help detect lung cancer. The positive findings are part of a pilot project which started four years ago.”

Week Ending July 10, 2011

Endosonography Improves Quality of Life in Lung Cancer Patients - Study
“Lung cancer patients who underwent endoscopic testing ahead to surgery had a better quality of life at the end of the staging process, finds data presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).”

First study of lung cancer patient who never smoked
Scientists claim to have carried out a first-of-its-kind study of a patient with lung cancer, who never smoked.

“An international team has sequenced the entire DNA and RNA of the 61-year-old woman with metastatic adenocarcinoma of the lung, the findings of which are published in the 'Journal of Thoracic Oncology'.”

Possible Chemopreventive Role for Celecoxib in Lung Cancer
(HealthDay News) – “Celecoxib significantly reduces bronchial Ki-67 labeling index (Ki-67 LI), and may be a potential chemopreventive agent for lung cancer in former smokers, according to a study published in the July issue of Cancer Prevention Research.”

Young mother takes on fight against lung cancer
“It was mid-July, 2010. Days away from her 40th birthday, northwest Greensboro resident Alicia Riddle and her husband Scott were about to leave for San Francisco to celebrate their 15th wedding anniversary.”

Celebrex might prevent lung cancer in former smokers, early studies suggest
“The Cox-2 inhibitor celecoxib, better known under the brand name Celebrex, might be able to prevent lung cancer in former smokers, researchers said Wednesday. Studies in a small group of people suggest that the drug, which is normally used to treat arthritis and some other inflammatory diseases, prevents a proliferation of cells that is normally a precursor of lung cancer, the researchers reported in the journal Cancer Prevention Research. But a great deal more research will be necessary to show that the drug actually prevents the initiation of cancer and then that it prevents deaths, experts said.”

Women, elderly, minorities poorly represented in lung cancer drug trial data submitted to US FDA
“Women, older people and minorities are enrolled less frequently in lung cancer drug trials and the numbers do not reflect the prevalence of lung cancer in these populations, according to research presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer (IASLC).”

Synta Announces Presentation of Small Cell Lung Cancer Results at IASLC 14th World Conference on Lung Cancer
-Ganetespib more potent than 17-AAG in SCLC cells-

“Synta Pharmaceuticals Corp. today announced that results presented at the International Association for the Study of Lung Cancer (IASLC) 14th World Conference on Lung Cancer showed that ganetespib (STA-9090) is more potent than 17-AAG and is synergistic with doxorubicin in a model of small cell lung cancer. Ganetespib is a potent inhibitor of heat shock protein 90 (Hsp90) currently being studied in a broad range of clinical trials with approximately 400 patients treated to date. Ganetespib is structurally unrelated to first-generation, ansamycin-family Hsp90 inhibitors such as 17-AAG or IPI-504.”

Accuray's CyberKnife and TomoTherapy Systems Highlighted at World Conference on Lung Cancer
“Accuray Incorporated, the premier radiation oncology company, announced new clinical data highlighting the ability of its CyberKnife® Robotic Radiosurgery System and its TomoTherapy® Radiation Therapy System to treat a wide range of patients with lung cancer and lung metastases. The new outcome data was presented at the 14th World Conference on Lung Cancer, the leading global forum for lung cancer and thoracic oncology research and practice, which took place July 3-7, 2011 in Amsterdam, The Netherlands.”

ARIAD Announces Presentation on Its Investigational Lung Cancer Drug Candidate, AP26113, a Dual Inhibitor of ALK and EGFR, at World Conference on Lung Cancer
“ARIAD Pharmaceuticals, Inc. today announced the presentation of new preclinical data on AP26113, its investigational dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR), demonstrating that its novel profile allows targeted inhibition of these two clinically validated oncogenic kinases in non-small cell lung cancer (NSCLC). These data are being presented at the International Association for the Study of Lung Cancer (IASLC) 14th World Conference on Lung Cancer being held in Amsterdam, The Netherlands.”

Cigarette Warning Labels Cause Increase to National Quit Line
“Cigarette warning labels that contain graphic images are having the desired effect: calls into a national smoker's quit line more than doubled the day the altered packages were unveiled.”

Week Ending July 3, 2011

Study bolsters evidence that screening reduces lung cancer deaths
Closer analysis of a trial finds that spiral CT scans pose few serious complications and can cut lung cancer rates among smokers and ex-smokers by 20%.

“Screening smokers and ex-smokers with spiral CT scans can reduce lung cancer deaths by 20% without triggering too many dangerous or unnecessary tests that sometimes result from cancer screening programs, researchers reported Wednesday in the New England Journal of Medicine.”

Hospitals Offering Lung Cancer CT Scans
“Using CT scans to screen smokers for lung cancer cuts the risk of death from the disease by 20 percent, according to a new study by the National Cancer Institute published in the New England Journal of Medicine.”

Lung Cancer Alliance Launches New Website "Screen for Lung"
“Today, Lung Cancer Alliance (LCA), the only national organization dedicated solely to support services and advocacy for all those living with or at risk for lung cancer, launched a new website, "ScreenforLung", which is intended to help guide decisions about lung cancer screening.“

UT MD Anderson Debuts Lung Cancer Screening Program
Experts mobilize after national clinical trial shows CT scanning reduces deaths by 20 percent

“Current and former heavy smokers can now be screened more effectively for lung cancer. Results from the National Lung Screening Trial (NLST) revealed that detecting small lung cancers with computed tomography (CT) reduces lung cancer specific mortality by 20 percent.”

Sarah Cannon Research Institute Abstracts Accepted for Presentation at the World Conference on Lung Cancer
The International Association for the Study of Lung Cancer (IASLC) has chosen four Sarah Cannon Research Institute (SCRI) abstracts for presentation, including a Conference President’s Selection, at the 14th World Conference on Lung Cancer, which takes place July 3-7 in Amsterdam, The Netherlands.

Pfizer Announces Data Presentations For Investigational Compounds In Its Lung Cancer
Preliminary Overall Survival Data from a Phase 2 Study Comparing PF-00299804 to Erlotinib in Second-/Third-line Advanced Non-Small Cell Lung Cancer

“Pfizer Inc. will present early and mid-stage data from its lung cancer portfolio, including PF-00299804 (PF-299) an investigational, oral, pan-HER inhibitor;(1) and crizotinib, an investigational, oral, first-in-class compound that inhibits the anaplastic lymphoma kinase, or ALK,(2) at the International Association for the Study of Lung Cancer's (IASLC) 14th World Conference on Lung Cancer (WCLC), July 3-7 in Amsterdam, The Netherlands.”


Week Ending June 19, 2011

Ariad's ALK Inhibitor Could Be Huge Step Forward in Lung Cancer Treatment
“One year ago, an anaplastic lymphoma kinase (ALK) inhibitor called crizotinib developed by Pfizer for non-small-cell lung cancer demonstrated it shrank the tumors in most of the 82 patients after two months of treatment.”

GRACE, LUNGevity announce free webinar program to highlight lung cancer research
“LUNGevity Foundation and GRACE announce a free webinar program to provide the highlights in lung cancer research from the American Society for Clinical Oncology (ASCO) Annual Meeting held June 3-6, 2011 in Chicago.”

Cancer deaths and education: Exploring the link
“The American Cancer Society's annual report, released Friday, holds good news for just about everybody: The overall cancer death rate is dropping steadily, and fewer people are getting the dreaded diagnosis in the first place. But as the organization notes, one group has largely been left behind in this march toward progress.”

UTSW study: Lung cancer drugs promising
“Some lung-cancer patients at the University of Texas Southwestern Medical Center in Dallas are responding well to potential new drug therapies targeting genetic mutations.”

Mother's book soothes fears of cancer patients' kids
“Catherine Selene Benitone, 37, continues to ease the arduous task of discussing the topic of cancer with children, even after her death Sunday.”

CT Scan proves sucessful in treating lung cancer
“The earlier lung cancer can be caught, the greater the chances of surviving it. According to a recent study, screening patients with a CT scan instead of a chest x-ray greatly improves the chances of catching the disease before it's too late.”

European Trial Upholds Use of Erlotinib in EGFR-Mutant Lung Cancer
CHICAGO – “Data from the prospective, phase-III EURTAC trial cement the need for personalized treatment of lung cancer patients but also leave clinicians in uncharted waters in terms of treatment options.”

Week Ending June 12, 2011

IASLC releases interactive staging tool in thoracic oncology
“The International Association for the Study of Lung Cancer (IASLC), the only global organization dedicated to the study of lung cancer, today announced the release of its Staging Atlas in Thoracic Oncology as a downloadable application for iPad, iPhone, Android or BlackBerry.”

ASCO: Pemetrexed Delays Lung Cancer Progression
“Maintenance therapy with pemetrexed (Alimta) appears to significantly extend progression-free survival in patients with advanced nonsquamous non-small cell lung cancer -- although the difference when compared with placebo is modest.”

Moffitt helps put lung cancer drug on fast track
TAMPA – “Moffitt Cancer Center is part of a national study of a lung cancer drug that is proving to be so effective, it's on a fast track for government approval.”

Consortium Tracking Tumor Mutations to Guide Lung Cancer Treatment, Clinical Trial Inclusion
“Members of the Lung Cancer Mutation Consortium are using genetic information to guide treatment and clinical trial participation for individuals with lung adenocarcinoma, Memorial Sloan-Kettering Cancer Center medical oncologist Mark Kris said at the American Society of Clinical Oncology annual meeting here yesterday.”

Large-Scale Study Shows Correlation of EGFR Mutations with Smoking and Men
“Researchers from Memorial Sloan Kettering Cancer Center and the Weill Medical School of Cornell University have shown an association of epidermal growth factor receptor (EGFR) mutations among tumor samples from men and those who smoke cigarettes. Traditionally, these two characteristics have not been thought to be associated with EGFR mutations, but are common in never-smokers and women. D’Angelo et al. now state that if only non-smokers and women were genetically tested for harboring an EGFR mutation, 57% of all EGFR mutations would be missed, supporting evidence from previous studies.”

UNC Scientist Receives Grant to Address Lung Cancer Disparities
Chapel Hill, NC – “Samuel Cykert, MD, has received a $1.8 million five-year grant from the American Cancer Society (ACS) to study “Lung Cancer Surgery: Decisions Against Life Saving Care.””

MSU professor aims to educate Montanans about health hazards of radon
“When Laura Larsson moved to Montana from Oregon in 1998, she had no clue what radon was.
Today the 39-year-old mother and professor is well-educated about the gas and is on a mission to educate others about the potential health hazard.”

Lung Cancer Alliance Praises National Leadership for Their Continued Support for a Call to Action on Lung Cancer

WASHINGTON, May 13, 2011 – “Today, Lung Cancer Alliance (LCA) praised national leaders for their continued and steadfast support for LCA's call to action for a more coordinated and comprehensive public health strategy to address the nation's most lethal cancer.”

Cancer Treatment Experts Detail Promising New Radiosurgical Techniques for Lung and Liver Cancer Patients
LONDON, May 12, 2011 /PRNewswire/ -- “European cancer experts have reported on developments of some promising radiosurgical techniques for treating lung and liver cancer using new linear accelerator technology from Varian Medical Systems (NYSE: VAR). Among the achievements outlined at a packed "Emerging Technologies Symposium" at the annual conference of the European Society for Therapeutic Radiology and Oncology (ESTRO) in London was the ability to treat metastatic liver cancer, an often inoperable condition, with high dose rate radiosurgery by using RapidArc® radiotherapy on Varian's TrueBeam™ platform.”

Week Ending May 9, 2011

Researchers at UCLA to Use Nanoscale Vaults in Treating Lung Cancer
“Researchers at UCLA have engineered “vaults,” barrel-shaped nanoscale capsules found in the cytoplasm of mammalian cells, to slowly release chemokine CCL21 into tumors. CCL21 is a protein that, in pre-clinical studies in mice with lung cancer, stimulated the immune system to recognize and attack the cancer cells, said Leonard Rome, a researcher at UCLA’s Jonsson Comprehensive Cancer Center, associate director of the California NanoSystems Institutes and co-senior author of the study, which appeared in PLoS yesterday, May 3rd, 2011.”

Half of U.S. states have comprehensive smoke-free laws
More action is required to limit exposure to secondhand smoke, a CDC report says.

“In light of research in the past decade showing that even brief exposure to secondhand smoke can cause harm, half of all states in the U.S. have implemented comprehensive laws banning smoking in bars, restaurants and private-sector work sites, according to the Centers for Disease Control and Prevention. The targeted locations have been considered major sources of secondhand smoke.”

Cancer researcher sees scientific work as calling
DALLAS—“Like many ministers, Misty Shields received her calling when she was a teenager. In her case, she believed God called her to be a lung cancer researcher.”

UF researchers find quiet protein speaks loudly in fight against cancer
“Filed under Health, Research on Tuesday, May 3, 2011. GAINESVILLE, Fla. — When a movie character says, “It’s too quiet,” that’s usually a sign something bad may happen. Now, University of Florida researchers have discovered that when variations of a certain protein in our cells are too quiet, it may add to the risk that someone will develop lung cancer. When scientists restored the protein to its normal, active self, its cancer-inhibiting properties reappeared.”

Air pollution outside, sure, but indoor air might not be great either
“We know the air outside is bad—the latest headlines tell us half of Americans live in regions with unhealthy ozone or particle pollution, which can be particularly risky for people with chronic lung disease or asthma. But exposure to pollution doesn’t stop when you duck indoors.”

Week Ending May 2, 2011

Lung Cancer Screening Trial Opens for High Risk Individuals
“Smokers and ex-smokers are at higher risk for developing lung cancer, but researchers still don’t know which individuals are most likely to develop the deadly disease. Now, these high-risk individuals who live in the Nashville area are eligible to participate in the Nashville Lung Cancer Screening Trial, a research project to determine which biomarkers could be helpful for early diagnosis.”

LUNGevity Foundation Creates Inaugural Lung Cancer PRISM Award
Recognizes television series for effectively portraying lung cancer challenges

“LUNGevity Foundation is awarding CBS daytime television series “The Bold and the Beautiful” the inaugural PRISM LUNGevity Award at the 15th Annual PRISM Awards presented by the Entertainment Industries Council, Inc. on Thursday, April 28, 2011 at the Beverly Hills Hotel.”

Dr. Anil Potti Has a Special Interest in Providing Care To Patients With Lung Cancer
“Just like all cancers, lung cancer results from an uncontrolled growth of abnormal cells in one or both the lungs. Just like all cancers, lung cancer results from an uncontrolled growth of abnormal cells in one or both the lungs. It is one of the most common reasons of death caused due to cancer in both men and women across the globe. The American Cancer Society estimated 222,520 new cases of lung cancer to be diagnosed in the U.S. in 2010. As per the U.S. National Cancer Institute, one out of every 14 men and women in the U.S. will suffer from lung cancer at some point in their lifetime. Lung cancer is mainly a disease of the elderly.”


Week Ending April 24, 2011

Diagnosis was call to action for McBee
“When doctors told Darlington resident Kim McBee that she had lung cancer, she didn’t wonder why it had happened to her.”

Lung Cancer: Sara Bennett's Story
“Early detection combined with advanced technology helps Scottsdale mom stave off two bouts of lung cancer.”

Clinical Evidence Takes Center Stage at TomoTherapy Americas User Education Symposium
“Emerging clinical evidence was highlighted at the Americas User Education Symposium hosted by TomoTherapy Incorporated month in Charleston, S.C. With more than 80 TomoTherapy customers in attendance, the meeting featured presentations from clinicians who submitted abstracts on how TomoTherapy® radiation therapy technology is being effectively used for the treatment of numerous types of cancers. The meeting also explored TomoTherapy-related clinical and dosimetric trials, and how the system can be used to deliver stereotactic body radiation therapy (SBRT).”

Lung Cancer Risk Higher for Those Who Start Smoking Early
“People who start smoking at an early age increase their risk of developing lung cancer later in life, according to Dr. Otis Brawley, Chief Medical Officer at the American Cancer Society.”

CDC: More States Need to Go ‘Smoke-Free’
Progress Seen in Reduction of Secondhand Smoke Exposure, but CDC Calls for Tougher Action

“People are banned by law from smoking in bars, restaurants, and work sites in half of all states in the U.S., but more action is needed to reduce heart disease and lung cancer caused by secondhand smoke, the CDC says in a new report.”

Not Enough Clinical Trials for Lung Cancer?
“Clinical trials for cancer are the road to the future. As the method by which new treatments are examined -- treatments that might just work better than what we currently have -- these studies are essential to make a difference in survival rates down the line. Given the fact that lung cancer is the leading cause of lung cancer in both men and women, and the survival rate is lower than that with many other cancers, it would seem that clinical trials for lung cancer would be abundant. So are they?”

Local Man Taking a Stand Against Lung Cancer
SALISBURY, Md.- “People on Delmarva- and even Oprah- are helping one local man take a stand against lung cancer.”

Synta Readying 2 Key Lung Cancer Trials
“Synta Pharmaceuticals is gearing up to begin two key clinical trials in non-small cell lung cancer (NSCLC) with its two novel compounds – ganetespib and elesclomol – that are being closely watched by potential Big Pharma partners.”

Patient Physician Communication Lacking for Lung Cancer
“A diagnosis of lung cancer raises a flurry of questions to be addressed. Not just about treatment options, but about concerns regarding practical needs, emotional symptoms, spiritual concerns, and difficult topics, such as when to consider hospice or draw up a living will.”

Study Demonstrates a Significant Increase in Lung Nodule Detection with Riverain Medical’s SoftView Chest X-ray Application
“SoftView Application Allows Physicians to Locate More Nodules than Unaided Chest X-ray Riverain Medical, an industry leader and innovator in computer-aided detection (CAD) and advanced visualization technologies, today announced the publication of a peer-reviewed study in Radiology demonstrating that radiologists using Riverain Medical’s SoftView® bone suppression application with chest X-rays significantly increased their detection of lung nodules proven to be primary lung cancer.”

Week Ending April 18, 2011

Lung Cancer Alliance Announces Additional $12.8 Million in Federal Research Funding For Lung Cancer
“Today, Lung Cancer Alliance(LCA) announced that its efforts to secure increased federal research funding for lung cancer achieved another victory as an additional $12.8 million was included in the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) which was part of the FY2011 budget compromise approved by Congress. The President is expected to sign it into law tonight.”

U.S. Cancer Doctors Back Genetic Tests to Assess Lung Cancer Patients
“Patients with the most common form of lung cancer should be genetically tested prior to treatment to predict whether they might be helped by Roche Holding AG (ROG) Tarceva and AstraZeneca Plc (AZN)’s Iressa tumor medicines, a U.S. physicians’ group said.”

UC program targets metastatic brain cancers
“Lynne Mayo learned she had lung cancer the hard way - after it spread to her brain.”

Global Phase III Trial With Selective c-MET Inhibitor Tivantinib (ARQ 197) Starts Enrolling Patients in Europe
“Daiichi Sankyo announced today that it has begun enrolling patients in Europe into a large, multinational phase III trial of tivantinib (ARQ 197). Tivantinib is an investigational small molecule inhibitor of the c-MET receptor tyrosine kinasein final phase of clinical development for the treatment of advanced, non-squamous, non-small cell lung cancer (NSCLC).”

Big plans for 'Oprah' donations
“The PJ Aldridge Foundation,a local charity with the goal of raising money to combat lung cancer, has already moved mountains for its cause despite less than a year of existence.”

Stereotactic Body Radiotherapy Effective Lung Cancer Treatment
“In the last decade, cancer has overtaken heart disease as the number one cause of mortality in the United States. Lung cancer remains the leading cause of cancer death in both men and women, and the American Cancer Society estimates that 30 percent of all cancer deaths are tobacco related.”

Jackson Lab cancer research gains $429K grant
“A researcher at Jackson Laboratory in Bar Harbor, Maine, has received a $429,933 to expand her work in studying microRNA therapies for lung cancer.”

NIH funds investigation of inhaled lung cancer treatment
“Just as inhaling cigarette smoke can cause lung cancer, inhaling medication may treat it. Two researchers at Albert Einstein College of Medicine of Yeshiva University have received a five-year, $2.4 million grant from the National Institutes of Health to clinically develop an inhaled therapy for lung cancer – to be used before the cancer becomes malignant and spreads.”

Precision Therapeutics' ChemoFx® Demonstrates Significant Role in Selection of Chemotherapy Doublets in Non Small Cell Lung Cancer
“Drs. Rodney Landreneau and Matthew Schuchert from the University of Pittsburgh presented a new non small cell lung cancer study at the 2011 Society of Surgical Oncology (SSO) conference in San Antonio, Texas.”

Week Ending April 11, 2011

Lung Cancer Alliance Heralds Reintroduction of Bi-Partisan and Bi-Cameral Lung Cancer Mortality Reduction Act
“Today, Lung Cancer Alliance(LCA) praised congressional leadership for again stepping forth and reintroducing federal legislation to provide for a compassionate and comprehensive plan of action for lung cancer – the leading cause of cancerdeath.”

Nearly 20% of Lung Cancer Patients Keep Smoking
Patients,caregivers need strong support, interventions to quit, study finds

(HealthDay News) – “Many Patients diagnosed with lung cancer -- as well as their family caregivers --continue to smoke even though doing so may jeopardize their recovery andlong-term health outcome, says a study sponsored by the U.S. National Cancer Institute.”

Cancer Symptoms – Lung Cancer Patients FoundSusceptible To High-Risk Forms Of Human Papillomavirus
“Researchers with the International Agency for Research on Cancer (IARC) have found that people with lung cancer were significantly more likely to have several high-risk forms of human papillomavirus (HPV) antibodies compared to those who did not have lung cancer. These results, which were presented at the AACR 102nd Annual Meeting2011, held April 2-6, indicate that HPV antibodies are substantially increased in people with lung cancer.”

Doctor with famous ties talks about lung cancer at Phoebe
Albany, Ga. – “You might be surprised to learn that lung cancer kills 1/3 of female patients, more than any other form of the disease.”

Understanding why lung cancer spreads
MIT biologists pinpoint a genetic change that helps tumors move to other parts of the body.

“MIT cancer biologists have identified a genetic change that makes lung tumors more likely to spread to other parts of the body. The finding offers new insight into how lung cancers metastasize and could help identify drug targets to combat metastatic tumors,which account for 90 percent of cancer deaths.”

Endobronchial Dysplasia Could Be Marker for LungCancer Chemoprevention
Endobronchial dysplasia appears useful as a biomarker for measuring the success of lung cancer chemoprevention, investigators reported at the annual meeting of the American Association for Cancer Research.”

UC Irvine surgeon performs county’s first roboticlobectomy for lung cancer
Orange, Calif. – “UC Irvine Medical Center surgeon Dr. Amir Abolhoda has performed Orange County’s first robot-assisted lobe removal to treat lung cancer.”

Leading Cause Of Lung Cancer Found In Ore. Homes
A $10 Test Can Determine If Your Home Has Dangerous Levels of Radon PORTLAND, Ore.-- -- “Say the words "lung cancer" and cigarettes and secondhand smoke jump to mind.”

Miller: Colorado will continue as a lung cancer leader for years to come
“I have been the leader of the University of Colorado Cancer Center’s Lung Cancer Program since 1994. The Program, now known as the Lung/Head and Neck Cancer Program, shifted to add our growing head and neck cancer research portfolio. It makes sense that these two sites of cancer occurrence live within the same program due to their relation to tobacco as a cause. Next issue you’ll hear from Xiao-Jing Wang, PhD, who leads that side of the group.”

Blood Test Holds Hope for Spotting Lung Cancer in Nonsmokers
Small study identified disease 83% of the time, but more research needed, experts say

(HealthDay News) – “Preliminary research suggests that a blood test could offer evidence that a nonsmoker has lung cancer, potentially giving doctors a new diagnostic tool.”

Week Ending April 3, 2011

Lung cancer deaths fall for women
“American women have come a long way, and at last that includes the fact that they, like men, are finally dying less often from lung cancer.”

Lung Cancer Drug Fails in Late-Stage Study
Amgen Inc. and Takeda Pharmaceutical Co. announced Wednesday that a drug being developed by the two companies for cancer patients failed in late-stage testing to improve overall survival rates for lung cancer patients.”

Study finds stress of cancer makes it harder to quit smoking, despite health benefits
“It seems to be one of the great puzzlements of life — a smoker diagnosed with cancer who continues to puff away.”

CT Trial Results Change Lung Cancer Screening Landscape
“The results from the National Lung Screening Trial constitute a "game changer" for lung cancer screening, Dr. James R. Jett said at the annual meeting of the National Association for Medical Direction of Respiratory Care.”

Soy helps radiation kill cancer cells: Study
“A component in soybeans appears to increase radiation's ability to kill lung cancer cells, a new study shows.”

Elevated Levels Of Radon Found In Some Metro Schools
NASHVILLE, Tenn. – “Just-released tests results from the Metro Nashville Health Department show elevated levels of the cancer-causing gas radon in some Nashville classrooms.”

NewLink Genetics to Present Phase 2 Data of Its HyperAcute(R) Lung Immunotherapy at AACR 102nd Annual Meeting 2011
NewLink Genetics Corporation today announced that additional data from its Phase 2 clinical trial of the Company's investigational HyperAcute® Lung cancer immunotherapy will be presented during a poster session at the American Association for Cancer Research 102nd Annual Meeting 2011 in Orlando, Florida.”

The Addario Lung Cancer Medical Institute Launches Unique Lung Cancer Research Initiative
“The Addario Lung Cancer Medical Institute (ALCMI, voiced as "Alchemy") today announced the enrollment of the initial subjects into its inaugural clinical trial known as CASTLE, targeting 250 subjects over two years among academic and community medical centers in the United States. CASTLE stands for Collaborative Advanced Stage Tissue Lung Cancer study.”


Week Ending March 28, 2011

Learning How to Conduct Cancer Clinical Trials
“In 2001, Howard "Jack" West was in his final year as a medical oncology fellow at the Fred Hutchinson Cancer Research Center in Seattle, Washington, when he wanted to develop a clinical trial to test a molecularly targeted therapy for advanced bronchioloalveolar lung cancer.”

Nonsmokers not immune from lung cancer
“Ben Mount does not smoke, has never smoked, and wasn’t exposed to second-hand smoke growing up. Yet Mount has lung cancer.”

Freshmedx Lung Cancer Diagnostic Successfully Evaluates Indeterminate Lung Masses
Freshmedx today announced the completion of a clinical trial at a major medical center in Baltimore. Freshmedx’s proprietary Computerized Bioconductance Test (CB Test™) showed favorable results in distinguishing between benign and malignant indeterminate masses by chest CT in undiagnosed individuals with lung cancer symptoms. In this trial, the CB Test™ demonstrated 90% sensitivity and 92% specificity in distinguishing between benign and malignant masses confirmed by biopsy or stable disease.”

Experimental radioprotective drug safe for lung cancer patients, says Pitt study
“Patients with advanced non-small cell lung cancer can safely take an experimental oral drug intended to protect healthy tissue from the effects of radiation, according to a study led by researchers at the University of Pittsburgh Cancer Institute (UPCI) and published in this month's issue of Human Gene Therapy.”

Genetic mutations: why lung cancer drugs fail
“Even with drugs that are genetically targeted to attack them, tumors have many ways to dodge, evade, and survive. By uncovering these escape routes, two new studies offer hope for therapies tailored to cut them off.”

Cancer victims' spouses prone to get sick
“Spouses looking after a partner with cancer often get sick themselves, a new study says. Partners who cared for spouses with cancer were 25% more likely to be hit with a disease in the year following the diagnosis of their loved one.”

Lung cancer cells 'could predict best treatment'
“Research has suggested that determining the number of lung cancer cells circulating in a person's blood could determine how aggressive the cancer is.”

Rockford doctor awaits lung cancer screening guidelines
ROCKFORD — “Picture a kid waiting for Christmas to get an idea of how anxiously Dr. JC Michel, a SwedishAmerican Health System pulmonologist, is anticipating guidelines that could lead to development of a CT screening program for lung cancer.”

Improved cancer coverage for firefighters
“Workers compensation coverage is set to improve for Saskatchewan firefighters, who are often exposed to dangerous materials.”

Hospice Use with Lung Cancer Varies by Race
“It's hard for me to imagine not having had the services of hospice as I cared for family members who were dying. Emotionally - after making the decision as a family for hospice - it felt like we were transported from a lonely desolate island to an Eden of sorts. From a social support standpoint that is.”

Helping Lung Cancer Patients Achieve Positive Outcomes at Montefiore
“To effectively treat lung cancer, the disease must be caught in early stages, as the five-year survival rate for advanced, metastasized lung cancer is generally less than 5%. At Montefiore, several advanced bronchoscopy techniques, including autofluorescence bronchoscopy and navigational bronchoscopy, are used after an abnormal finding on a chest X-ray or CT scan is detected to allow for diagnosis at the earliest possible opportunity.”

Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients
Medtronic of Canada Ltd. today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients.i The study found that Kyphon Balloon Kyphoplasty provided cancer patients better back-specific function, more rapid back pain relief and improved quality of life compared with non-surgical care one month after treatment.”

Week Ending March 21, 2011

Rendezvous With an Earthquake for a Hiroshima Native
Ritsuko Komaki, 67, grew up in Hiroshima after the atomic bombing there. Her experience led her to become a radiation oncologist, and she now works at M.D. Anderson Cancer Center in Houston, Texas, treating lung cancer. Komaki was minutes from landing at Tokyo's main airport when the earthquake struck last week.”

Study Puts Notch on the Jagged Edge of Lung Cancer Metastasis
“Researchers discovered a new, key component in the spread of lung cancer as well as a likely way to block it with drugs now in clinical trial. The study was published today (Monday, March 14) in the Journal of Clinical Investigation.”

Surveyed U.S. Oncologists Estimate That 67 Percent of Patients with Advanced Non-Small-Cell Lung Cancer Who Complete First-Line Induction Therapy Receive Maintenance Therapy
“Changes Within the Reimbursement Landscape Will Not Significantly Constrain or Promote the Use of Maintenance Therapies for NSCLC Over the Next 12 Months, According to a New Report from Decision Resources”

Putting a Price Tag on Synta's Lead Drug Activities
“This year is shaping up as a transformational year for Synta (SNTA), which is making progress on multiple fronts with its lead agent ganetespib (formerly known as STA-9090).”

Pack-a-day smokers declining
“Fewer U.S. adults are smoking, and those who do smoke are on average smoking less, according to a new study in the Journal of the American Medical Association.”

California's quitting smoking faster than the rest of the U.S.
“California has been kicking its smoking habit far more successfully than the rest of America – and it may be due to more than four decades of antismoking state policies.”

FDA panel backs menthol cigarette ban
“Pulling menthol cigarettes from the shelves would benefit the health of Americans, an FDA advisory panel recommended in a long-awaited report yesterday.”

Lung cancer in older women 'doubled'
“Lung cancer among women over the age of 60 has doubled since the mid 1970s.”

Giving Cancer Patients A Lift!
“Juan Mercado-Resto kissed his family goodbye as he headed off to Rochester General Hospital. Juan says it was tough learning he had lung cancer and tougher to undergo treatments three times a week. But Juan now has one less thing to worry about. A local company called Web Title Agency has adopted him.”

Week Ending March 14, 2011

Patients of Lung Cancer May Get Some Exercise Help
“Lung Cancer patients should exercise to get fit as a report by Australian researchers reveals that non-small cell lung cancer patients might get benefited from exercise.”

Emphysema Found In Blood May Help You Quit Smoking
“Okay, so you smoke cigarettes in a regular basis with no plans to quit. Lung cancer and respiratory ailments could be looming, but how do you know? A new blood test is being developed that detects the early development of emphysema well before symptoms occur and provide some form of peace of mind. Not all smokers develop emphysema, but finding out far in advance may just be the wakeup call you need.”

Invisible and Odorless, Radon Poses Risks to Lungs
Houses in Midwest and Northeast are especially vulnerable, experts say

(HealthDay News) – “It may be hard to think of radiation as a present and serious environmental health concern in the United States, much less one with the potential to affect nearly every home in the country.”

Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
Sanofi-aventis and Regeneron Pharmaceuticals, Inc. today announced results from the Phase III VITAL trial evaluating the investigational agent aflibercept (VEGF Trap) for the second-line treatment of non-small cell lung cancer (NSCLC). The data showed that adding aflibercept to the chemotherapy drug docetaxel did not meet the pre-specified criteria for the primary endpoint of improvement in overall survival compared with a regimen of docetaxel plus placebo (HR=1.01, CI: 0.868 to 1.174).“

New treatment shows promise for lung cancer patients
“Testing lung cancer on a molecular level could offer new insights on how to fight the disease, according to researchers from the University of Colorado Cancer Center.”

An Early Diagnosis of Lung Cancer Might Help In Better Treatment
“Reports suggest that lung cancer cases among women aged 60 and over have increased in last 30 years and smoking is the main cause behind this dreading figures.”

Surgical Robot Assists in Lung Cancer Surgery
“Robotic-assisted lung cancer surgery is most often performed on patients diagnosed with early-stage lung cancer, and studies prove that it is safe and effective.”

Vitamin B6 And Common Amino Acid May Help Prevent Lung Cancer
“Research that was published in the Journal of the American Medical Association suggests that individuals with higher levels of vitamin B6 and methionine — an amino acid commonly found in meat and other protein sources — are at a lower risk for developing lung cancer than those who are deficient in the nutrients.”

World's first artificial partial lung transplant 'a success'
“The world's first artificial partial lung transplant carried out on a 78-year-old patient with lung cancer has been declared a success, two and a half years after the operation took place.”


Week Ending February 28, 2011

Lung Cancer Survivor: I Never Smoked
Doctors say lung cancer is becoming an epidemic for young people and non-smokers.

“Many times when you think lung cancer, many people think of the stereotype of an older person who has smoked all their life, but doctors say that just isn't true.”

Palliative Care Could Prolong Life, Reduce Suffering for Lung Cancer Patients
“While many have never heard of palliative care, or even know what it means, new research published in The New England Journal of Medicine has shown that getting early palliative care, in addition to regular medical treatment, helped patients with lung cancer live three months longer when compared with patients given standard care.”

Thousands climb Denver stairs to fight lung cancer
DENVER – “56 stories, 1,098 steps. Over 2,200 Coloradans conquered both Sunday to raise money to fight lung cancer and lung disease.”

New Test for Detecting Lung Cancer in Non-smokers
“Scientists from the Mayo Clinic in Rochester, US have now developed a new, cheaper and faster method to detect certain types of lung cancer in patients with no history of smoking.”

Red meat also linked to higher risk of lung cancer
“The British government reportedly issued dietary guidelines Friday to recommend that British people should eat less red meat to reduce their risk for colorectal cancer or bowel cancer.”

Week Ending February 22, 2011

World's largest lung cancer screening conference to address benefits of CT scans
“Who: The world's leading lung cancer screening researchers, doctors and advocates. The International Lung Cancer Consortium (ILCCO) and International Early Lung Cancer Action Program (I-ELCAP) Screening Conferences.”

CU Cancer Center study shows promise for lung tumor treatment
“Researchers at the University of Colorado Cancer Center are drawing on milk thistle extract to fight the spread lung cancer in lab mice.”

Fish Oil May Improve Chemotherapy Response in Lung Cancer Patients
“If you've been diagnosed with lung cancer, I'm sure you've wondered what else could possibly be done to improve your survival. What about all those supplements displayed in the health food store? Is there anything that is "missing" that could be combined with conventional medicine that might make a difference?”

'Death with dignity' debate likely to be emotional
MONTPELIER, Vt. – “Hans Penner isn't ready to die just yet. The retired Dartmouth College religion professor has another book he wants to finish writing first. But, with the diagnosis of stage 4 inoperable lung cancer he got last fall, Penner knows it's coming. He just wants to be in control when it does.”

Local singer records, donates album after successful battle with cancer
“Flu-like symptoms sent singer and musician Dwight Fitch to the emergency room, but his wife, Connie Fitch, could see the mass on the X-ray. When the diagnosis came back as stage 3 lung cancer, they knew they were in for the fight of their lives.”

U.S. House Slashes Funding for Public Health, Clean Air, Clean Water
“Early this morning, the U.S. House of Representatives passed a funding bill that environmentalists say amounts to the biggest attack on clean air and clean water in recent history.”

Lung Cancer Alliance Hails Veterans Organizations Call for Pilot CT Screening Programs
“Lung Cancer Alliance (LCA) hailed four key veterans organizations that called yesterday for pilot CT screening programs for veterans at high risk for lung cancer and included the recommendation in the Independent Budget - an annual document listing their top priorities for federal funding.”

Study Shows Improved Detection of Lung Cancer Nodules with Riverain Medical’s CAD Chest X-ray Technology
Riverain Medical, an industry leader and innovator in computer-aided detection (CAD) and advanced visualization technologies, today announced a poster presentation, “A Superior Chest X-Ray Computer-Aided Detection (CXR CADe) Application: A Reader Study,” has been published on the European Society of Radiology’s website. Investigators compared two versions of Riverain Medical’s computer-aided detection (CAD) technology, OnGuard™ 5.1 and OnGuard 1.0. The study found radiologists using OnGuard 5.1 were able to detect smaller lung nodules, including those that were primary lung cancer.”

Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients
Medtronic Inc., today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients.i The study found that Kyphon Balloon Kyphoplasty provided cancer patients better back-specific function, more rapid back pain relief and improved quality of life compared with non-surgical care one month after treatment.”

Idaho State University doctoral grad to engage in lung cancer research at prestigious MD Anderson Cancer Center
“Idaho State University doctoral recipient Vikas Bhardwaj has been accepted for a post-doctoral fellowship to engage in lung cancer research at one of the world's preeminent cancer-research institutions, the University of Texas MD Anderson Cancer Center in Houston, Texas.”

Whether They Smoke or Not, Patients Say Lung Cancer Diagnosis Carries a Social Stigma
LOS ANGELES – “Patients with lung cancer, whether they smoke or not, feel stigmatized because their disease is strongly associated with smoking, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research. Oncology nurse researcher Janine K. Cataldo, PhD, RN, from the University of California, San Francisco (UCSF) presented the findings.”

AACR Award For Lifetime Achievement In Cancer Research For Susan Band Horwitz, Ph.D.
“Susan Band Horwitz, Ph.D., will receive the Eighth AACR Award for Lifetime Achievement in Cancer Research. Horwitz conducted pioneering research by discovering the mechanism of action of the chemotherapeutic drug paclitaxel (Taxol), which prompted the development of this drug as an important therapy for many common solid tumors, including ovarian, breast, and lung carcinomas. Her work has also contributed to the understanding of how microtubules function in normal and malignant cells and why stabilization of microtubules is a promising target for drug discovery.”

Doctors group urges honesty for dying patients
“Patients don't want to hear that they're dying, and doctors don't want to tell them. But new guidance for the nation's cancer specialists says they should be upfront and do it far sooner.”

St. Mary's Cyber Knife Program Participating in Multi Site Study
Huntington, WV, (HNN) – “St. Mary’s Regional Cancer Center announced today it will participate in the national phase III clinical trial STARS (Stereotactic Radiosurgery vs. Surgery) comparing surgical and nonsurgical treatment for early-stage NSCLC (Non-Small Cell Lung Cancer), the most common form of lung cancer.”

Canada's double standard on asbestos
“Canada continues to sell -- and advocate -- cancer-causing asbestos to other countries despite strictly limiting the domestic use of the mineral.”

Where there's smoke, there's trouble
“Where there is wood smoke, there is fire - as well as invisible toxins you could be inhaling.“

Parkview joins global lung cancer study
Researchers to compare traditional surgery and Cyberknife radiosurgery

“Parkview Health is participating in an international study to compare two different treatments for early-stage non-small-cell lung cancer.”

New American Indian Cancer Foundation SEEKS TO END CANCER DISPARITIES
“Among Native Americans, cancer is the leading cause of death, according to the Indian Health Service (IHS). Studies show that Native Americans are more likely to suffer certain types of cancers, like lung or colorectal cancer.”

Cancer declines more quickly for men
“Fewer people are getting cancer in Wisconsin than in the late-1990s, according to a new report from the American Cancer Society, but declines in the deadly disease have been greater among men than women. For men, cancer cases (per capita) fell 14 percent between 1997 and 2007, but for women, they only declined 7 percent.”

Many Patients Don’t Take Part in Cancer Studies
Study Shows Doctors Often Fail to Tell Patients About Ongoing Clinical Trials

“Just an estimated 2% to 4% of adults who are newly diagnosed with cancer participate in clinical trials even though there are more than 8,000 such trials that are actively recruiting. One reason is that they may not know about these trials because their doctors may not tell them, suggests a new study in the Journal of the National Cancer Institute.”

Shadow on Your Chest X-Ray? Welcome to Groundhog Day
“This article will take a little long to unfold, but, hey, it's winter. What else do you have to do?”

New Classification of Lung Adenocarcinoma Calls for EGFR Testing
“A joint effort by three medical groups has enabled a variety of specialists to join pathologists in revising the classification of lung adenocarcinoma, and they’ve made some major changes.”

Week Ending February 14, 2011

Whether They Smoke or Not, Patients Say Lung Cancer Diagnosis Carries a Social Stigma
LOS ANGELES – “Patients with lung cancer, whether they smoke or not, feel stigmatized because their disease is strongly associated with smoking, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research. Oncology nurse researcher Janine K. Cataldo, PhD, RN, from the University of California, San Francisco (UCSF) presented the findings.”

AACR Award For Lifetime Achievement In Cancer Research For Susan Band Horwitz, Ph.D.
“Susan Band Horwitz, Ph.D., will receive the Eighth AACR Award for Lifetime Achievement in Cancer Research. Horwitz conducted pioneering research by discovering the mechanism of action of the chemotherapeutic drug paclitaxel (Taxol), which prompted the development of this drug as an important therapy for many common solid tumors, including ovarian, breast, and lung carcinomas. Her work has also contributed to the understanding of how microtubules function in normal and malignant cells and why stabilization of microtubules is a promising target for drug discovery.”

Doctors group urges honesty for dying patients
“Patients don't want to hear that they're dying, and doctors don't want to tell them. But new guidance for the nation's cancer specialists says they should be upfront and do it far sooner.”

St. Mary's Cyber Knife Program Participating in Multi Site Study
Huntington, WV, (HNN) – “St. Mary’s Regional Cancer Center announced today it will participate in the national phase III clinical trial STARS (Stereotactic Radiosurgery vs. Surgery) comparing surgical and nonsurgical treatment for early-stage NSCLC (Non-Small Cell Lung Cancer), the most common form of lung cancer.”

Canada's double standard on asbestos
“Canada continues to sell -- and advocate -- cancer-causing asbestos to other countries despite strictly limiting the domestic use of the mineral.”

Where there's smoke, there's trouble
“Where there is wood smoke, there is fire - as well as invisible toxins you could be inhaling.“

Parkview joins global lung cancer study
Researchers to compare traditional surgery and Cyberknife radiosurgery

“Parkview Health is participating in an international study to compare two different treatments for early-stage non-small-cell lung cancer.”

New American Indian Cancer Foundation SEEKS TO END CANCER DISPARITIES
“Among Native Americans, cancer is the leading cause of death, according to the Indian Health Service (IHS). Studies show that Native Americans are more likely to suffer certain types of cancers, like lung or colorectal cancer.”

Cancer declines more quickly for men
“Fewer people are getting cancer in Wisconsin than in the late-1990s, according to a new report from the American Cancer Society, but declines in the deadly disease have been greater among men than women. For men, cancer cases (per capita) fell 14 percent between 1997 and 2007, but for women, they only declined 7 percent.”

Many Patients Don’t Take Part in Cancer Studies
Study Shows Doctors Often Fail to Tell Patients About Ongoing Clinical Trials

“Just an estimated 2% to 4% of adults who are newly diagnosed with cancer participate in clinical trials even though there are more than 8,000 such trials that are actively recruiting. One reason is that they may not know about these trials because their doctors may not tell them, suggests a new study in the Journal of the National Cancer Institute.”

Shadow on Your Chest X-Ray? Welcome to Groundhog Day
“This article will take a little long to unfold, but, hey, it's winter. What else do you have to do?”

New Classification of Lung Adenocarcinoma Calls for EGFR Testing “A joint effort by three medical groups has enabled a variety of specialists to join pathologists in revising the classification of lung adenocarcinoma, and they’ve made some major changes.”

Week Ending February 6, 2011

Move To Cut Lung Cancer
UK – “A LUNG cancer screening programme is being launched in a bid to save more than 8,000 lives a year.”

CT scans join lung cancer battle
“Lung cancer is by far the deadliest of all cancers. And Kentucky, which has the highest percentage of cigarette smokers in the country, also has the highest rates of lung cancer cases and lung cancer deaths.”

New body scanner gives doctors a new look at cancer
“In years past, lung cancer was almost always a death sentence and it is still a challenge to treat. But in this special Medical Moment Just Before Six, there is a new body scanner, the only of its kind in our area, that is giving doctors and patient's hope like never before.”

Second hand smoke increases lung cancer risk among children
“A recent research showed that daily exposure of children to second hand smoke have tripled their risk of lung cancer and an increased risk of respiratory problems than those who grew up in a smoke-free environment.”

National Minority Quality Forum Launches the Lung Cancer Atlas
“In recognition of World Cancer Day, the National Minority Quality Forum today launched the Lung Cancer Atlas ( This novel resource enables users to map lung cancer prevalence estimates and total counts at the zip-code level for the United States as well as for individual states, federal and state legislative districts. In addition to mapping lung cancer prevalence estimates overall, the atlas maps lung cancer by age, gender, and race/ethnicity (Source: National Cancer Institute's Surveillance Epidemiology and End Results (SEER) Program).”

Decline in lung cancer threatened by schoolgirls taking up smoking
“WALES could be turning the corner on lung cancer, with new figures showing a decline in the number of cases in men and women.”

Lung cancer leaves no one to blame
Nonsmokers with disease face stigma, lack of research funding

“A nonsmoker, Connie Brookshier of Cocoa never suspected her persistent cough might be caused by lung cancer.”

Quitting Is A Drag, But So Is Lung Cancer
“Back when I was a fiscally struggling undergrad (my, how things don’t change), I took a series of lab-rat gigs at VCU. The money wasn’t great, but it paid out right away and I didn’t have to donate anything other than my time, patience and a little blood. The studies were only for tobacco research and required that I be a smoker. This is a preface to the bigger story, the current one of my becoming a non-smoker.”

Tarzana doctor to appear on 'Bold and the Beautiful' as show marks 6,000th episode by addressing cancer
“The message is bold, and if it gets through to the millions of people it's targeting, it could be beautiful. Hoping to spotlight an illness that comes up short in fundraising efforts due to its association with cigarette smokers, lung cancer survivors will appear on "The Bold and the Beautiful" to dramatize the frustrations shared by sufferers of the disease.”

Early Detection of Lung Cancer: Protein Biomarkers in Exhaled Air
“The earlier cancers can be detected, the better the chances of a cure. Researchers are now working to develop a new diagnostics platform with which the illness can be diagnosed in its early stages, even during a visit to the general practitioner: protein biomarkers in exhaled air divulge the presence of pathological cells in the lung.”


Week Ending January 30, 2011

Early Successful Readout of Tarceva Study in a Distinct Form of Lung Cancer
-- EURTAC is the First Phase III Study to Show Progression-Free Survival Benefit of First-Line Tarceva in a Western Population with Advanced Lung Cancer With EGFR Mutations --

Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.

Turf Battles Brewing Over Lung Cancer
SAN DIEGO -- A turf war is brewing over new technologies being explored for lung cancer diagnosis and treatment -- potentially setting up thoracic surgeons for battles on multiple fronts, experts warned.

CT scans join lung cancer battle
Lung cancer is by far the deadliest of all cancers.
And Kentucky, which has the highest percentage of cigarette smokers in the country, also has the highest rates of lung cancer cases and lung cancer deaths.

Clinical trials give cancer patients hope, time
Linda Shreve stopped by her doctor's office Monday to get a shot. John Quinn stopped by his to be examined for upper respiratory problems.

Anti-estrogens linked to fewer lung cancer deaths
(Reuters Health) - Anti-estrogen drugs such as tamoxifen may reduce a woman's risk of dying from lung cancer, suggests a new study. The analysis included a very small number of women with lung cancer, however, and the findings do not mean that women should take these drugs to prevent or treat lung cancer, doctors say.

Week Ending January 24, 2011

Grants help school districts test for radon
Illinois – “State agencies are handing out $38,000 to help 50 school districts test their buildings' water systems for the radioactive gas known as radon.”

Cetuximab Rash Promotes Better Lung Cancer Outcome
“According to a recent study, the presence of a rash brought about by the lung cancer drug used, Cetuximab (Erbitux) yields better outcomes for the patients. Accordingly, the German researchers have discovered such startling finding.”

The Five Most Dangerous Professions for Lung
“Lung disease is one of health problems that frequently occur in urban areas. Pollution and a lack of parks and trees make a lot of people who live in cities often have respiratory distress.”

Research Supports Pain Relief at End of Life
“Massage therapy is valuable component of hospice care, for its ability to effect relaxation and pain relief. New research supports the use of pain-relieving interventions for end-of-care.”

Cancer Costs Estimated to Soar in Coming Decade, Mesothelioma Care is No Exception
“According to a study conducted at the National Cancer Institute (NCI), the cost of cancer care in the United States is expected to rise from an estimated $125 billion last year to $158 billion by the year 2020. The cancers were classified according to 16 cancer types including breast, colorectal and lung.”

Study Finds No Benefit From Statins for Lung Cancer Prevention
“Studies aren't always perfect. And sometimes we hold hopes for a breakthrough, only to have them dashed. Such may be the case for the role of statins - a category of cholesterol lowering medications including drugs such as Lipitor (atorvastatin) and Zocor (simvastatin) - in lung cancer prevention.”

Controlling symptoms can lead to improved quality of life for end of life patients
LOUISVILLE, Ky. – “Healthcare workers can most directly affect quality of life (QOL) of patients with advanced stage lung cancer by helping manage symptoms such as pain, lack of energy, shortness of breath, coughing, difficulty sleeping and dry mouth, according to a study recently published in the journal Oncology Nursing Forum.”

Week Ending January 16, 2011

Challenge accepted: Cancer survivor defies odds, plans 2nd marathon
“Mark Conley was dealing as best he could after having surgery to remove a cancerous tumor in his left lung in the late-1980s. For the 17-year-old athlete, life had taken on a whole new meaning.”

Hill's 'huge miracle:' New 45th District Senator healthy again after pill eliminates his lung cancer
“Diagnosed with lung cancer in March of 2009, first-year Sen. Andy Hill faced a grim future — and with each stage of treatment, the prognosis only got worse.”

Tickly, dry, chesty: What that nasty cough REALLY means
“Just about everywhere you turn, it seems, ­people are coughing and spluttering. Yet a recent study by the University of Leicester found that although coughs are one of the most common ­complaints seen by GPs, only 60 per cent of people find a cause.”

Lung Cancer Survival Improves with Drug
“A discovery about the use of the medication, Erlotinib (Tarceva) after chemotherapy improves non-small cell lung cancer survival as suggested by a new study.”

RADON TESTING: Lung cancer survivor encourages Iowans to test homes
“This month the Iowa Department of Public Health is reminding Iowans to test their home for radon. The poisonous gas affects more households in Iowa than any other state in the country.”

Pfizer Inc. Introduces New Drug for Lung Cancer
“A new drug called Crizotinib currently used in experimental studies is believed to shrink the tumors in patients suffering from non-small cell lung cancer. By altering the genes of a specific enzyme, the anaplastic lymphoma kinase, a cancer patient is said to be benefited.”

Syndax Announces Publication of Entinostat NSCLC Data in Cancer Research
“Syndax, a clinical-stage epigenetics oncology company, announced publication of data of entinostat combined with the demethylating agent Vidaza® (azacitidine) showing effect in reducing tumor burden in differentiated tumor cells in animal tumor models of non-small cell lung cancer (NSCLC). The data is being published in the January 15, 2011 issue of Cancer Research.”

One-fifth of survivors reported cancer-related chronic pain
“Results of a survey of 199 cancer survivors revealed that 19.5% had chronic pain related to their disease and 42.6% reported experiencing pain since diagnosis.”

Mrs. Central Coast takes up the fight against lung cancer
“A Central Coast woman is using her prize power to raise awareness about lung cancer. Experts say it's the number one cancer killer for both men and women.”

Saving Lives: Detecting Lung Cancer Faster - Science Insider
“Each year, more people die from lung cancer than breast cancer, colon cancer and prostate cancer combined. Early detection is key to beating the disease. Now, a new technology is helping detect lung cancer tumors earlier.”

Week Ending January 9, 2011

Bevacizumab Maintenance Extends Lung Cancer Survival in Community Practice
CHICAGO – “Bevacizumab maintenance after first-line chemotherapy for advanced non–small cell lung cancer was associated with longer overall survival in a retrospective study of 403 patients who were treated in outpatient community settings.”

New drug gets ‘personal’ with patient’s cancer
“Paula Hart was just 46 when she starting having shortness of breath, along with a nagging cough and intermittent pain in her left shoulder.”

Rockland County Giving Out Free Radon Kits
NEW YORK (WCBS 880) – “Health officials are offering free radon testing kids to low income families and senior citizens in Rockland County.”

Men vs Women in Lung Cancer Incidence and Survival
“Though we often place men and women into the same pot when we talk about lung cancer, to do so isn't really any different than saying we wear the same style clothes. And I'd have to argue that understanding the differences in lung cancer between the sexes is more important than a fashion show.”

Lung Cancer Advocacy Summit 2011
“The National Lung Cancer Partnership is excited to announce the 4th Annual Lung Cancer Advocacy Summit: Tools for Change from April 28 through May 1, 2011, in Denver, CO.”

Ipilimumab Shows Modest Activity in Advanced NSCLC
CHICAGO – “The novel immunotherapy ipilimumab was active in combination with paclitaxel and carboplatin chemotherapy in first-line advanced lung cancer, but a phase II trial did not deliver the blockbuster results recently observed in metastatic melanoma.”

TB linked to higher risk for lung cancer
“Patients with tuberculosis had a risk for lung cancer that was approximately 11 times higher than those without tuberculosis, according to recent study results.”

New Lung Cancer Treatment
“Researchers at Harvard Medical School and the Massachusetts General Hospital in Boston, Massachusetts are developing a new lung cancer drug for Pfizer. Currently in the early phases of a stage 3 clinical trial, Crizotinib was successful in shrinking non-small cell lung cancer tumors by at least 30% in 47 of 82 patients exhibiting cancers with a specific mutation in the anaplastic lymphoma kinase gene.”

Week Ending January 3, 2011

Helping the brave fight their final battle
Veterans Affairs launches initiative to assist aging veterans reliving the traumas of their war experiences

“The Vietnam veteran dying of lung cancer was cowering in the corner, emotionally distraught, unwilling to talk to anyone.”

U.S. Health Care Reform Tops Health News for 2010
Food safety reform and the flu epidemic that fizzled also made headlines this year

(HealthDay News) – “In a year packed with health news headlines, the pick for top spot was still easy: the passage last spring of the long-sought health care reform bill.”

Deadliest Cancer Getting Smaller Chunk of Research Dollars
Lung cancer spending should focus more on detection and treatment, advocates say

(HealthDay News) – “Consider this: Lung cancer is the most deadly form of cancer in the United States, killing about 157,300 people every year -- more than colon, breast and prostate cancer combined, according to the U.S. National Institutes of Health.”

Experimental cancer treatment shows promise
December 30, 2010 (CHICAGO) (WLS) – “A new, experimental treatment may have made Glenn Mitchell's lung cancer disappear.”

Blood Test To Spot Cancer Gets Big Boost From J&J
“A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office.”

New Year's Resolution for Lung Cancer Survivors
I have been thinking for days about New Year's resolutions for lung cancer survivors. But what to write? I certainly don't want to add to anyone's "should do - could do" list. That would be contrary to my thoughts hoping you pamper yourself. And the resolutions we are bombarded on the news seem so unimportant and trivial next to a diagnosis of lung cancer.”

EPA urges all homes be tested for Radon
“One in 15 homes in the United States has elevated radon levels, and 21,000 deaths are attributed to this cause each year, second only to smoking in causing lung cancer deaths.”

Study finds evidence of increased lung cancer risk among tuberculosis patients
“Although a clear association of tuberculosis with lung cancer remains to be established, a new study published in the January issue of the Journal of Thoracic Oncology provides compelling evidence of increased lung cancer risk among people with tuberculosis.”

When Lung Cancer Patients Can't Sleep They May Self-Medicate with Tobacco, Study Finds
“What many of us take for granted -- a good night's sleep -- may be unattainable for those with lung cancer. Lung cancer patients comprise a subgroup of cancer patients who are most vulnerable to sleep disturbances.”

Belinostat Plus Tarceva® Trial in Patients with Non-Small Cell Lung Cancer Enrolls First Patient
“Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, and Topotarget A/S announced today that the first patient has been dosed in an Investigator Initiated Trial of belinostat in combination with Tarceva® for patients with Non-Small Cell Lung Cancer (NSCLC). The primary objective of the study is to evaluate the safety of belinostat in combination with Tarceva and to generate efficacy data in terms of progression-free survival, response rate and overall survival in patients with NSCLC.”

Future of proton-beam radiation therapy shines among inoperable lung cancers
“Research from Japan documenting remarkable survival rates among patients with inoperable lung cancer may only hint at the potential of proton-beam radiation therapy. The study out of the Proton Medical Research Center in Tennoudai, Japan, documented high survival rates for 55 patients suffering from stage I inoperable non-small-cell lung cancer.”

Last Updated on Monday, 02 January 2012 22:46
Caring Ambassadors
Copyright • 2013
Caring Ambassadors
Site designed by Ferguson Lynch
Caring Ambassadors
P.O. Box 1748
Oregon City, OR 97045
503-632-9038 (Fax)